syndrome	score	normalized_score
INSULINOMA	0.34920660000000003	100.0
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.3055556	87.4999498863996
INSULIN AUTOIMMUNE SYNDROME	0.27777799999999997	79.54546105371432
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.25114939999999997	71.92000380290634
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.25	71.59085767565675
HYPERPARATHYROIDISM 2	0.25	71.59085767565675
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.25	71.59085767565675
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	71.59085767565675
DYSTONIA 6, TORSION	0.25	71.59085767565675
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.25	71.59085767565675
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.23448280000000002	67.14729904875796
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.216667	62.04550544004609
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.2	57.27268614052541
ROMANO-WARD SYNDROME	0.2	57.27268614052541
46,XY OVOTESTICULAR DISORDER OF SEX DEVELOPMENT	0.2	57.27268614052541
TRICHOTHIODYSTROPHY	0.2	57.27268614052541
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.1825396	52.27266609508525
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.175	50.11360037295972
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.175	50.11360037295972
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.17287818000000002	49.50598871842629
GRANULOMATOSIS WITH POLYANGIITIS	0.16817076	48.15795577746812
PROPROTEIN CONVERTASE 1/3 DEFICIENCY	0.166667	47.72733390491474
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.166667	47.72733390491474
CUTANEOUS SMALL VESSEL VASCULITIS	0.166667	47.72733390491474
PITYRIASIS RUBRA PILARIS	0.166667	47.72733390491474
HEREDITARY FRUCTOSE INTOLERANCE	0.166667	47.72733390491474
PEMPHIGUS VULGARIS	0.166667	47.72733390491474
PFAPA SYNDROME	0.166667	47.72733390491474
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.1400384	40.10187665410677
SLC35A2-CDG	0.12650376	36.226050710381756
PHENYLKETONURIA	0.125	35.795428837828375
CENTRAL PRECOCIOUS PUBERTY	0.125	35.795428837828375
FAMILIAL THORACIC AORTIC ANEURYSM AND AORTIC DISSECTION	0.125	35.795428837828375
ANEURYSM OR DILATATION OF ASCENDING AORTA	0.125	35.795428837828375
THORACOLARYNGOPELVIC DYSPLASIA	0.125	35.795428837828375
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.12142860000000001	34.77271048141702
LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.11111099999999999	31.818127148799586
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.11111099999999999	31.818127148799586
ACYL-COA DEHYDROGENASE 9 DEFICIENCY	0.11111099999999999	31.818127148799586
OGDEN SYNDROME	0.11111099999999999	31.818127148799586
HUNTINGTON DISEASE-LIKE 3	0.11111099999999999	31.818127148799586
RENAL AGENESIS, BILATERAL	0.11111099999999999	31.818127148799586
FRAGILE X MENTAL RETARDATION SYNDROME	0.11111099999999999	31.818127148799586
SANDIFER SYNDROME	0.11111099999999999	31.818127148799586
AUTOSOMAL RECESSIVE ATAXIA DUE TO PEX10 DEFICIENCY	0.11111099999999999	31.818127148799586
BENIGN PAROXYSMAL TORTICOLLIS OF INFANCY	0.11111099999999999	31.818127148799586
EPISODIC ATAXIA TYPE 4	0.11111099999999999	31.818127148799586
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.11111099999999999	31.818127148799586
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.11111099999999999	31.818127148799586
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.1055556	30.227263745874218
CONGENITAL ISOLATED ACTH DEFICIENCY	0.0900384	25.783705118975416
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.0844828	24.192784443363895
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.0844828	24.192784443363895
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.0844828	24.192784443363895
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.0844828	24.192784443363895
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.0844828	24.192784443363895
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.07809527000000001	22.363629438847948
OCULOAURICULOVERTEBRAL SPECTRUM WITH RADIAL DEFECTS	0.07317966000000001	20.95597849525181
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.07293236000000002	20.88516081883905
SILVER-RUSSELL SYNDROME	0.07142860000000001	20.454538946285666
TEMPLE SYNDROME	0.07142860000000001	20.454538946285666
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.07142860000000001	20.454538946285666
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.07142860000000001	20.454538946285666
%609197 GLUCOCORTICOID DEFICIENCY 3; GCCD3;;FAMILIAL GLUCOCORTICOID DEFICIENCY 3; FGD3;;GLUCOCORTICOID DEFICIENCY 2, FORMERLY; GCCD2, FORMERLY	0.07142860000000001	20.454538946285666
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.07142860000000001	20.454538946285666
SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA	0.07142860000000001	20.454538946285666
WILLIAMS-BEUREN SYNDROME; WBS	0.06327054000000001	18.118368896807794
HEMOCHROMATOSIS, TYPE 1	0.06176678000000001	17.68774702425441
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.06176678000000001	17.68774702425441
SECKEL SYNDROME 10; SCKL10	0.06176678000000001	17.68774702425441
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.05737094	16.428939201034574
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.05705936	16.339714083296247
PYGMY	0.05641948	16.15647585125825
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.05641948	16.15647585125825
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.05641948	16.15647585125825
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.05641948	16.15647585125825
NEUROGENIC ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.056410260000000004	16.153835580427174
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.055555600000000004	15.909092210742868
X-LINKED SIDEROBLASTIC ANEMIA	0.055555600000000004	15.909092210742868
ESTROGEN RESISTANCE SYNDROME	0.055555600000000004	15.909092210742868
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.055555600000000004	15.909092210742868
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.055555600000000004	15.909092210742868
HYPOGONADISM, MALE, WITH MENTAL RETARDATION AND SKELETAL ANOMALIES	0.055555600000000004	15.909092210742868
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.055555600000000004	15.909092210742868
OBESITY DUE TO SIM1 DEFICIENCY	0.055555600000000004	15.909092210742868
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.055555600000000004	15.909092210742868
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.055555600000000004	15.909092210742868
HYPERTRIGLYCERIDEMIA, FAMILIAL	0.055555600000000004	15.909092210742868
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.055555600000000004	15.909092210742868
HEMOCHROMATOSIS, TYPE 4; HFE4	0.055555600000000004	15.909092210742868
WHITE-SUTTON SYNDROME; WHSUS	0.055555600000000004	15.909092210742868
ESTROGEN RESISTANCE; ESTRR	0.055555600000000004	15.909092210742868
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.055555600000000004	15.909092210742868
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.055555600000000004	15.909092210742868
%309620 MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD;;CHRISTIAN SYNDROME; CHRS	0.055555600000000004	15.909092210742868
ANIRIDIA	0.055555600000000004	15.909092210742868
HYPERLIPOPROTEINEMIA, TYPE IV	0.055555600000000004	15.909092210742868
ATAXIA-TELANGIECTASIA WITH GENERALIZED SKIN PIGMENTATION AND EARLY DEATH	0.055555600000000004	15.909092210742868
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.055555600000000004	15.909092210742868
THIOUREA TASTINGPHENYLTHIOCARBAMIDE TASTING, INCLUDED	0.0526316	15.071765539368384
46,XY DISORDER OF SEX DEVELOPMENT DUE TO 5-ALPHA-REDUCTASE 2 DEFICIENCY	0.0526316	15.071765539368384
SCALP-EAR-NIPPLE SYNDROME; SENS	0.0526316	15.071765539368384
CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL DOMINANT	0.0526316	15.071765539368384
274210 THYMIC APLASIA WITH FETAL DEATH	0.0526316	15.071765539368384
STEINERT MYOTONIC DYSTROPHY	0.0526316	15.071765539368384
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.0526316	15.071765539368384
MENOPAUSE, NATURAL, AGE AT, QUANTITATIVE TRAIT LOCUS 1	0.0526316	15.071765539368384
ECTODERMAL DYSPLASIA WITH ADRENAL CYST	0.0526316	15.071765539368384
CUTIS VERTICIS GYRATA, THYROID APLASIA, AND MENTAL RETARDATION	0.0526316	15.071765539368384
BIEMOND SYNDROME II	0.0526316	15.071765539368384
MYASTHENIA GRAVIS; MG	0.0526316	15.071765539368384
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.05150376	14.748793407684735
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.05	14.318171535131352
DIABETES MELLITUS, TRANSIENT NEONATAL, 3	0.05	14.318171535131352
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.05	14.318171535131352
PENILE AGENESIS	0.05	14.318171535131352
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.05	14.318171535131352
CAUDAL REGRESSION SEQUENCE	0.05	14.318171535131352
FEMORAL-FACIAL SYNDROME	0.05	14.318171535131352
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.05	14.318171535131352
MICROFORM HOLOPROSENCEPHALY	0.05	14.318171535131352
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.05	14.318171535131352
ESOPHAGEAL ATRESIA	0.05	14.318171535131352
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.05	14.318171535131352
PULMONARY ATRESIA-INTACT VENTRICULAR SEPTUM SYNDROME	0.05	14.318171535131352
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.05	14.318171535131352
SYMBRACHYDACTYLY OF HANDS AND FEET	0.05	14.318171535131352
MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 13	0.05	14.318171535131352
FOIX-CHAVANY-MARIE SYNDROME	0.05	14.318171535131352
PPARG-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.05	14.318171535131352
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.05	14.318171535131352
ULBRIGHT-HODES SYNDROME	0.05	14.318171535131352
GITELMAN SYNDROME	0.05	14.318171535131352
VERY LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.05	14.318171535131352
HYPOPLASTIC LEFT HEART SYNDROME	0.05	14.318171535131352
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.044871760000000004	12.84963113526491
ABLEPHARON-MACROSTOMIA SYNDROME	0.043200840000000004	12.371140751635279
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.03922214	11.231786569898736
BECKWITH-WIEDEMANN SYNDROME	0.03922214	11.231786569898736
MAL DE MELEDA	0.0384615	11.01396708996909
BLEPHAROCHALASIS AND DOUBLE LIP	0.0384615	11.01396708996909
LIP, HAMARTOMATOUS	0.0384615	11.01396708996909
AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION	0.0384615	11.01396708996909
ACROCEPHALOPOLYDACTYLY	0.0384615	11.01396708996909
BAZEX SYNDROME; BZX	0.0384615	11.01396708996909
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.0384615	11.01396708996909
CYCLIC NEUTROPENIA	0.0384615	11.01396708996909
PSEUDOXANTHOMA ELASTICUM; PXE	0.0384615	11.01396708996909
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0384615	11.01396708996909
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.0384615	11.01396708996909
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.0384615	11.01396708996909
SHPRINTZEN OMPHALOCELE SYNDROME	0.0384615	11.01396708996909
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0384615	11.01396708996909
VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL	0.0384615	11.01396708996909
TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS; TINU	0.0384615	11.01396708996909
%189700 TORUS PALATINUS AND TORUS MANDIBULARIS	0.0384615	11.01396708996909
LIP, MEDIAN NODULE OF UPPER	0.0384615	11.01396708996909
JUVENILE ABSENCE EPILEPSY	0.0384615	11.01396708996909
JUVENILE MYOCLONIC EPILEPSY	0.0384615	11.01396708996909
TONGUE CURLING, FOLDING, OR ROLLINGCLOVERLEAF TONGUE, INCLUDED	0.0384615	11.01396708996909
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.0344828	9.874612908232546
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.0344828	9.874612908232546
CONGENITAL ADRENAL HYPERPLASIA DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY	0.0344828	9.874612908232546
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.0344828	9.874612908232546
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.0344828	9.874612908232546
BECKWITH-WIEDEMANN SYNDROME	0.0344828	9.874612908232546
HYPOTONIA-CYSTINURIA SYNDROME	0.0344828	9.874612908232546
DILATED CARDIOMYOPATHY WITH ATAXIA	0.0344828	9.874612908232546
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.0344828	9.874612908232546
MODY	0.0344828	9.874612908232546
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.0344828	9.874612908232546
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.0344828	9.874612908232546
GLYCOGEN STORAGE DISEASE 0, LIVER	0.0344828	9.874612908232546
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.034444470000000005	9.863636597933716
WAARDENBURG SYNDROME, TYPE IIB	0.02928156	8.385167977924816
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.027777800000000002	7.954546105371434
OSTEOPENIA AND SPARSE HAIR	0.027777800000000002	7.954546105371434
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.027777800000000002	7.954546105371434
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.027777800000000002	7.954546105371434
EDINBURGH MALFORMATION SYNDROME	0.027777800000000002	7.954546105371434
DWARFISM, LEVI TYPE	0.027777800000000002	7.954546105371434
DIMPLES, FACIAL	0.027777800000000002	7.954546105371434
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.027777800000000002	7.954546105371434
OROFACIAL CLEFT 3	0.027777800000000002	7.954546105371434
CLEFT CHIN	0.027777800000000002	7.954546105371434
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.027777800000000002	7.954546105371434
FIBULAR DIMELIA-DIPLOPODIA SYNDROME	0.027777800000000002	7.954546105371434
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.027777800000000002	7.954546105371434
TESTICULAR REGRESSION SYNDROME	0.027777800000000002	7.954546105371434
15Q13.3 MICRODELETION SYNDROME	0.027777800000000002	7.954546105371434
SPEECH-LANGUAGE DISORDER 1	0.027777800000000002	7.954546105371434
22Q11.2 DISTAL DELETION SYNDROME	0.027777800000000002	7.954546105371434
15Q24 RECURRENT MICRODELETION SYNDROME	0.027777800000000002	7.954546105371434
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.027777800000000002	7.954546105371434
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.027777800000000002	7.954546105371434
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.027777800000000002	7.954546105371434
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.027777800000000002	7.954546105371434
CYANIDE, INABILITY TO SMELL	0.027777800000000002	7.954546105371434
NASAL ALAR COLLAPSE, BILATERAL	0.027777800000000002	7.954546105371434
NASAL GROOVE, FAMILIAL TRANSVERSE	0.027777800000000002	7.954546105371434
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.027777800000000002	7.954546105371434
NASAL BONES, ABSENCE OF	0.027777800000000002	7.954546105371434
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.027777800000000002	7.954546105371434
MENKES DISEASE	0.027777800000000002	7.954546105371434
HEMIFACIAL MICROSOMIA	0.023179659999999998	6.637806960120455
GOLDENHAR SYNDROME	0.021675899999999998	6.207185087567072
TOWNES-BROCKS SYNDROME	0.021675899999999998	6.207185087567072
EMANUEL SYNDROME	0.02072444	5.934721737790751
OTOMANDIBULAR SYNDROME	0.01844032	5.2806332984542665
MICROCEPHALY-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.01844032	5.2806332984542665
DUANE RETRACTION SYNDROME	0.01844032	5.2806332984542665
BRANCHIOOTIC SYNDROME	0.01844032	5.2806332984542665
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.01693656	4.850011425900885
OCULOAURICULOFRONTONASAL SYNDROME	0.01693656	4.850011425900885
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.01693656	4.850011425900885
MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA	0.01693656	4.850011425900885
AURICULOCONDYLAR SYNDROME	0.01693656	4.850011425900885
CHARGE SYNDROME	0.01693656	4.850011425900885
CRI-DU-CHAT SYNDROME	0.01693656	4.850011425900885
WILDERVANCK SYNDROME	0.01693656	4.850011425900885
16P13.11 MICRODELETION SYNDROME	0.0167694	4.802142914824634
HAMAMY SYNDROME; HMMS	0.0167694	4.802142914824634
LAMBERT SYNDROME	0.015265639999999999	4.371521042271251
LAMBERT SYNDROME	0.015265639999999999	4.371521042271251
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.015265639999999999	4.371521042271251
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.015265639999999999	4.371521042271251
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.015265639999999999	4.371521042271251
MACROSTOMIA-PREAURICULAR TAGS-EXTERNAL OPHTHALMOPLEGIA SYNDROME	0.015265639999999999	4.371521042271251
8P INVERTED DUPLICATION/DELETION SYNDROME	0.015265639999999999	4.371521042271251
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.015265639999999999	4.371521042271251
COFFIN-SIRIS SYNDROME 1; CSS1	0.015265639999999999	4.371521042271251
16Q24.3 MICRODELETION SYNDROME	0.015265639999999999	4.371521042271251
TREACHER-COLLINS SYNDROME	0.015265639999999999	4.371521042271251
PETERS PLUS SYNDROME	0.015265639999999999	4.371521042271251
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.015265639999999999	4.371521042271251
OCULOCEREBROCUTANEOUS SYNDROME	0.015265639999999999	4.371521042271251
ISOLATED COMPLEX I DEFICIENCY	0.01438161	4.118367178627207
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.01438161	4.118367178627207
TRISOMY 18-LIKE SYNDROME	0.01431418	4.099057692494929
%608572 BURN-MCKEOWN SYNDROME	0.01431418	4.099057692494929
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.01307693	3.7447545378581046
HOLOPROSENCEPHALY	0.01287785	3.6877453060738254
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.01287785	3.6877453060738254
FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG; FRTS4	0.01287785	3.6877453060738254
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.012653359999999999	3.6234595795153925
KABUKI SYNDROME	0.012030059999999999	3.444969253158445
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.012030059999999999	3.444969253158445
LOWE-KOHN-COHEN SYNDROME	0.012030059999999999	3.444969253158445
TRISOMY 13	0.012030059999999999	3.444969253158445
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.012030059999999999	3.444969253158445
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.012030059999999999	3.444969253158445
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.012030059999999999	3.444969253158445
COHEN SYNDROME	0.012030059999999999	3.444969253158445
TOWNES-BROCKS SYNDROME 1; TBS1	0.012030059999999999	3.444969253158445
%609166 BRANCHIOGENIC-DEAFNESS SYNDROME	0.012030059999999999	3.444969253158445
CHROMOSOME 10Q26 DELETION SYNDROME	0.0117019	3.3509962297390707
SMITH-KINGSMORE SYNDROME; SKS	0.011406010000000001	3.266264154228471
SIMPSON-GOLABI-BEHMEL SYNDROME	0.011406010000000001	3.266264154228471
MOSAIC TRISOMY 1	0.011149599999999999	3.19283770696201
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.011149599999999999	3.19283770696201
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.011149599999999999	3.19283770696201
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.011149599999999999	3.19283770696201
MICROTIA WITH MEATAL ATRESIA AND CONDUCTIVE DEAFNESS	0.011149599999999999	3.19283770696201
TRISOMY 18P	0.010526299999999999	3.0143473806050625
TRISOMY 8P	0.010526299999999999	3.0143473806050625
1Q44 MICRODELETION SYNDROME	0.010526299999999999	3.0143473806050625
FRONTONASAL DYSPLASIA 1; FND1	0.010526299999999999	3.0143473806050625
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.010526299999999999	3.0143473806050625
ISOTRETINOIN-LIKE SYNDROME	0.010526299999999999	3.0143473806050625
HEMIFACIAL MICROSOMIA WITH RADIAL DEFECTS	0.010526299999999999	3.0143473806050625
MICROPHTHALMIA, SYNDROMIC 4	0.010526299999999999	3.0143473806050625
ACITRETIN/ETRETINATE EMBRYOPATHY	0.010526299999999999	3.0143473806050625
KAPUR-TORIELLO SYNDROME	0.010526299999999999	3.0143473806050625
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.010526299999999999	3.0143473806050625
ACROCALLOSAL SYNDROME; ACLS	0.010526299999999999	3.0143473806050625
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.010526299999999999	3.0143473806050625
FRONTORHINY	0.010526299999999999	3.0143473806050625
BRANCHIOGENIC DEAFNESS SYNDROME	0.010526299999999999	3.0143473806050625
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.010526299999999999	3.0143473806050625
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.010526299999999999	3.0143473806050625
KAPUR-TORIELLO SYNDROME	0.010526299999999999	3.0143473806050625
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.010526299999999999	3.0143473806050625
BOR SYNDROME	0.010526299999999999	3.0143473806050625
FRONTONASAL DYSPLASIA	0.010526299999999999	3.0143473806050625
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.010526299999999999	3.0143473806050625
PREAURICULAR TAG, ISOLATED, AUTOSOMAL DOMINANT, 1	0.010526299999999999	3.0143473806050625
14Q22Q23 MICRODELETION SYNDROME	0.010526299999999999	3.0143473806050625
TETRAPLOIDY	0.010526299999999999	3.0143473806050625
BRANCHIOOTORENAL SYNDROME 1	0.010526299999999999	3.0143473806050625
EMANUEL SYNDROME	0.010526299999999999	3.0143473806050625
CRANIOTELENCEPHALIC DYSPLASIA	0.010526299999999999	3.0143473806050625
CAT-EYE SYNDROME (TYPE I)	0.010526299999999999	3.0143473806050625
CAT-EYE SYNDROME	0.010526299999999999	3.0143473806050625
DEXTROCARDIA	0.010526299999999999	3.0143473806050625
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.010526299999999999	3.0143473806050625
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.010526299999999999	3.0143473806050625
FRONTONASAL DYSPLASIA-SEVERE MICROPHTHALMIA-SEVERE FACIAL CLEFTING SYNDROME	0.010526299999999999	3.0143473806050625
MICROPHTHALMIA, LENZ TYPE	0.010526299999999999	3.0143473806050625
MONOSOMY 5P	0.010526299999999999	3.0143473806050625
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.010526299999999999	3.0143473806050625
FRONTOFACIONASAL DYSPLASIA	0.010526299999999999	3.0143473806050625
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.010526299999999999	3.0143473806050625
AURICULOCONDYLAR SYNDROME 1; ARCND1	0.010526299999999999	3.0143473806050625
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.010526299999999999	3.0143473806050625
3C SYNDROME	0.010526299999999999	3.0143473806050625
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.010526299999999999	3.0143473806050625
PROXIMAL SPINAL MUSCULAR ATROPHY	0.010526299999999999	3.0143473806050625
BARAITSER-WINTER SYNDROME 1; BRWS1	0.01003098	2.8725058461094375
ASPARTYLGLUCOSAMINURIA; AGU	0.00852722	2.441883973556055
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.00852722	2.441883973556055
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.00852722	2.441883973556055
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.008170430000000001	2.3397123651156653
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.008170430000000001	2.3397123651156653
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.008170430000000001	2.3397123651156653
SHEEHAN SYNDROME	0.008170430000000001	2.3397123651156653
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.008170430000000001	2.3397123651156653
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.008170430000000001	2.3397123651156653
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.008170430000000001	2.3397123651156653
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.008170430000000001	2.3397123651156653
CADASIL	0.008170430000000001	2.3397123651156653
HISTIDINURIA-RENAL TUBULAR DEFECT SYNDROME	0.008170430000000001	2.3397123651156653
DEAFNESS-CRANIOFACIAL SYNDROME	0.00791402	2.2662859178492045
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.00791402	2.2662859178492045
CRANIOFRONTONASAL DYSPLASIA	0.00791402	2.2662859178492045
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.00791402	2.2662859178492045
APERT SYNDROME	0.00791402	2.2662859178492045
DUANE-RADIAL RAY SYNDROME; DRRS	0.00791402	2.2662859178492045
CONGENITAL HYDROCEPHALUS	0.00791402	2.2662859178492045
15Q26 OVERGROWTH SYNDROME	0.00791402	2.2662859178492045
SAETHRE-CHOTZEN SYNDROME	0.00791402	2.2662859178492045
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.00791402	2.2662859178492045
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.00771494	2.2092766860649253
KEARNS-SAYRE SYNDROME; KSS	0.00771494	2.2092766860649253
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.00771494	2.2092766860649253
RENPENNING SYNDROME	0.00771494	2.2092766860649253
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.00771494	2.2092766860649253
WOLFRAM SYNDROME 2; WFS2	0.00771494	2.2092766860649253
RAMON SYNDROME	0.00771494	2.2092766860649253
DEAFNESS-ENAMEL HYPOPLASIA-NAIL DEFECTS SYNDROME	0.00771494	2.2092766860649253
NORRIE DISEASE	0.00771494	2.2092766860649253
NEUTRAL LIPID STORAGE MYOPATHY	0.00771494	2.2092766860649253
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.00771494	2.2092766860649253
JOHANSON-BLIZZARD SYNDROME	0.00771494	2.2092766860649253
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.00771494	2.2092766860649253
SHORT SYNDROME	0.00771494	2.2092766860649253
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.00771494	2.2092766860649253
WOODHOUSE-SAKATI SYNDROME	0.00771494	2.2092766860649253
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.00771494	2.2092766860649253
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.00771494	2.2092766860649253
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.00771494	2.2092766860649253
JOHANSON-BLIZZARD SYNDROME; JBS	0.00771494	2.2092766860649253
WOLFRAM SYNDROME	0.00771494	2.2092766860649253
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.00771494	2.2092766860649253
THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	0.00771494	2.2092766860649253
HISTIOCYTOID CARDIOMYOPATHY	0.00666667	1.9090904925622827
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.00666667	1.9090904925622827
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.00666667	1.9090904925622827
TENORIO SYNDROME; TNORS	0.00666667	1.9090904925622827
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.00666667	1.9090904925622827
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.00666667	1.9090904925622827
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 2; HHF2	0.00666667	1.9090904925622827
GLYCOGEN STORAGE DISEASE IXA	0.00666667	1.9090904925622827
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.00666667	1.9090904925622827
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.00666667	1.9090904925622827
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.00666667	1.9090904925622827
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.00666667	1.9090904925622827
HOMOZYGOUS 11P15-P14 DELETION SYNDROME	0.00666667	1.9090904925622827
TYROSINEMIA, TYPE I; TYRSN1	0.00666667	1.9090904925622827
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.00666667	1.9090904925622827
MEHMO SYNDROME; MEHMO	0.00666667	1.9090904925622827
2P21 MICRODELETION SYNDROME	0.00666667	1.9090904925622827
PROPIONIC ACIDEMIA	0.00666667	1.9090904925622827
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.00666667	1.9090904925622827
TIMOTHY SYNDROME; TS	0.00666667	1.9090904925622827
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.00666667	1.9090904925622827
GLYCEROL KINASE DEFICIENCY; GKD	0.00666667	1.9090904925622827
GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR	0.00666667	1.9090904925622827
WOLCOTT-RALLISON SYNDROME	0.00666667	1.9090904925622827
INFANTILE LIVER FAILURE SYNDROME 2	0.00666667	1.9090904925622827
OCULODENTODIGITAL DYSPLASIA	0.00666667	1.9090904925622827
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 5; MC3DN5	0.00666667	1.9090904925622827
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.00666667	1.9090904925622827
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34	0.00666667	1.9090904925622827
ENDOCARDIAL FIBROELASTOSIS	0.00666667	1.9090904925622827
DOPAMINE BETA-HYDROXYLASE DEFICIENCY	0.00666667	1.9090904925622827
CONGENITAL DISORDER OF GLYCOSYLATION	0.00666667	1.9090904925622827
SHASHI-PENA SYNDROME; SHAPNS	0.00666667	1.9090904925622827
MITOCHONDRIAL DNA DEPLETION SYNDROME 15 (HEPATOCEREBRAL TYPE); MTDPS15	0.00666667	1.9090904925622827
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.00666667	1.9090904925622827
MIRAGE SYNDROME; MIRAGE	0.00666667	1.9090904925622827
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.00666667	1.9090904925622827
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.00666667	1.9090904925622827
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.00666667	1.9090904925622827
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 5	0.00666667	1.9090904925622827
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.00666667	1.9090904925622827
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.00666667	1.9090904925622827
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.00666667	1.9090904925622827
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.00666667	1.9090904925622827
GROWTH HORMONE INSENSITIVITY SYNDROME	0.00666667	1.9090904925622827
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.00666667	1.9090904925622827
RIBOFLAVIN DEFICIENCY	0.00666667	1.9090904925622827
ORTHOSTATIC HYPOTENSION 2; ORTHYP2	0.00666667	1.9090904925622827
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.00666667	1.9090904925622827
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.00666667	1.9090904925622827
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.00666667	1.9090904925622827
BETA-KETOTHIOLASE DEFICIENCY	0.00666667	1.9090904925622827
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 3; MC3DN3	0.00666667	1.9090904925622827
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.00666667	1.9090904925622827
SOTOS SYNDROME	0.00666667	1.9090904925622827
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.00666667	1.9090904925622827
ADDISON DISEASE	0.00666667	1.9090904925622827
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.00666667	1.9090904925622827
LEPRECHAUNISM	0.00666667	1.9090904925622827
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.00666667	1.9090904925622827
NAVAJO NEUROHEPATOPATHY	0.00666667	1.9090904925622827
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.00666667	1.9090904925622827
HEMOCHROMATOSIS, NEONATAL	0.00666667	1.9090904925622827
COG8-CDG	0.00666667	1.9090904925622827
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.00666667	1.9090904925622827
PITUITARY STALK INTERRUPTION SYNDROME	0.00666667	1.9090904925622827
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.00666667	1.9090904925622827
PHOSPHOENOLPYRUVATE CARBOXYKINASE 2, MITOCHONDRIAL	0.00666667	1.9090904925622827
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.00666667	1.9090904925622827
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN DEBRANCHING ENZYME DEFICIENCY	0.00666667	1.9090904925622827
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.00666667	1.9090904925622827
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.00666667	1.9090904925622827
ACUTE ADRENAL INSUFFICIENCY	0.00666667	1.9090904925622827
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.00666667	1.9090904925622827
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.00666667	1.9090904925622827
PROPIONIC ACIDEMIA	0.00666667	1.9090904925622827
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.00666667	1.9090904925622827
MAPLE SYRUP URINE DISEASE; MSUD	0.00666667	1.9090904925622827
MULTIPLE ENDOCRINE NEOPLASIA, TYPE I	0.00666667	1.9090904925622827
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHORYLASE KINASE DEFICIENCY	0.00666667	1.9090904925622827
VISCERAL STEATOSIS, CONGENITAL	0.00666667	1.9090904925622827
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.00666667	1.9090904925622827
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.00666667	1.9090904925622827
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.00666667	1.9090904925622827
GALACTOSEMIA	0.00666667	1.9090904925622827
HEPATOCELLULAR CARCINOMA	0.00666667	1.9090904925622827
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.00666667	1.9090904925622827
FRUCTOSE AND GALACTOSE INTOLERANCE	0.00666667	1.9090904925622827
PANHYPOPITUITARISM	0.00666667	1.9090904925622827
DWARFISM, LOW-BIRTH-WEIGHT TYPE, WITH UNRESPONSIVENESS TO GROWTH HORMONE	0.00666667	1.9090904925622827
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.00666667	1.9090904925622827
PITUITARY DWARFISM WITH SMALL SELLA TURCICA	0.00666667	1.9090904925622827
GLUTARIC ACIDEMIA I; GA1	0.00666667	1.9090904925622827
MPI-CDG	0.00666667	1.9090904925622827
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.00666667	1.9090904925622827
GLYCOGEN STORAGE DISEASE IC; GSD1C	0.00666667	1.9090904925622827
CLASSIC GALACTOSEMIA	0.00666667	1.9090904925622827
LARON SYNDROME	0.00666667	1.9090904925622827
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.00666667	1.9090904925622827
CONGENITAL ISOLATED HYPERINSULINISM	0.00666667	1.9090904925622827
ORNITHINE TRANSCARBAMYLASE DEFICIENCY	0.00666667	1.9090904925622827
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.00666667	1.9090904925622827
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.00666667	1.9090904925622827
GENERALIZED GLUCOCORTICOID RESISTANCE SYNDROME	0.00666667	1.9090904925622827
GLYCOGEN STORAGE DISEASE VI	0.00666667	1.9090904925622827
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	0.00666667	1.9090904925622827
POLYENDOCRINE-POLYNEUROPATHY SYNDROME	0.00666667	1.9090904925622827
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.00666667	1.9090904925622827
HOLOPROSENCEPHALY 1; HPE1	0.00666667	1.9090904925622827
NEONATAL HEMOCHROMATOSIS	0.00666667	1.9090904925622827
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.00666667	1.9090904925622827
3-METHYLCROTONYL-COA CARBOXYLASE DEFICIENCY	0.00666667	1.9090904925622827
HYPOADRENOCORTICISM, FAMILIAL	0.00666667	1.9090904925622827
GLYCOGEN STORAGE DISEASE DUE TO LIVER GLYCOGEN PHOSPHORYLASE DEFICIENCY	0.00666667	1.9090904925622827
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.00666667	1.9090904925622827
PYRUVATE CARBOXYLASE DEFICIENCY	0.00666667	1.9090904925622827
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.00666667	1.9090904925622827
SHORT STATURE DUE TO GHSR DEFICIENCY	0.00666667	1.9090904925622827
SHORT STATURE DUE TO PARTIAL GHR DEFICIENCY	0.00666667	1.9090904925622827
GLYCOGEN STORAGE DISEASE IA	0.00666667	1.9090904925622827
MENKES DISEASE	0.00666667	1.9090904925622827
GLYCOGEN STORAGE DISEASE IB	0.00666667	1.9090904925622827
COSTELLO SYNDROME; CSTLO	0.00666667	1.9090904925622827
POST-TRAUMATIC PITUITARY DEFICIENCY	0.00666667	1.9090904925622827
PITUITARY APOPLEXY	0.00666667	1.9090904925622827
156620 MICROCEPHALY-DEAFNESS SYNDROME	0.00641026	1.835664045295822
ISOLATED HEMIHYPERPLASIA	0.00641026	1.835664045295822
PSEUDOAMINOPTERIN SYNDROME	0.00641026	1.835664045295822
POLYCYSTIC KIDNEY DISEASE 2	0.00641026	1.835664045295822
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.00641026	1.835664045295822
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.00641026	1.835664045295822
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.00641026	1.835664045295822
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.00641026	1.835664045295822
WITTEVEEN-KOLK SYNDROME	0.00641026	1.835664045295822
GRANT SYNDROME	0.00641026	1.835664045295822
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.00641026	1.835664045295822
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.00641026	1.835664045295822
FOCAL DERMAL HYPOPLASIA	0.00641026	1.835664045295822
MULLERIAN DUCT APLASIA, UNILATERAL RENAL AGENESIS, AND CERVICOTHORACICSOMITE ANOMALIES	0.00641026	1.835664045295822
CLEFT LIP/PALATE-DEAFNESS-SACRAL LIPOMA SYNDROME	0.00641026	1.835664045295822
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.00641026	1.835664045295822
SPINOCEREBELLAR ATAXIA TYPE 34	0.00641026	1.835664045295822
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.00641026	1.835664045295822
CLAPO SYNDROME	0.00641026	1.835664045295822
BENCZE SYNDROME	0.00641026	1.835664045295822
SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, ANDTRANSVERSE EARLOBE CREASE	0.00641026	1.835664045295822
WYBURN-MASON SYNDROME	0.00641026	1.835664045295822
CAFFEY DISEASE	0.00641026	1.835664045295822
TORTICOLLIS	0.00641026	1.835664045295822
CAMPTODACTYLY-JOINT CONTRACTURES-FACIAL SKELETAL DEFECTS SYNDROME	0.00641026	1.835664045295822
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.00641026	1.835664045295822
CHARGE SYNDROME	0.00641026	1.835664045295822
VASCULAR MALFORMATION, PRIMARY INTRAOSSEOUS	0.00641026	1.835664045295822
CURRY-JONES SYNDROME	0.00641026	1.835664045295822
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.00641026	1.835664045295822
PROTEUS SYNDROME	0.00641026	1.835664045295822
CRANIOFACIAL DYSSYNOSTOSIS	0.00641026	1.835664045295822
PFEIFFER SYNDROME	0.00641026	1.835664045295822
ELSAHY-WATERS SYNDROME; ESWS	0.00641026	1.835664045295822
SECKEL SYNDROME 1; SCKL1	0.00641026	1.835664045295822
FRONTONASAL DYSPLASIA-BIFID NOSE-UPPER LIMB ANOMALIES SYNDROME	0.00641026	1.835664045295822
FANCONI ANEMIA	0.00641026	1.835664045295822
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.00641026	1.835664045295822
DISTAL TRISOMY 15Q	0.00641026	1.835664045295822
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.00641026	1.835664045295822
CURRY-JONES SYNDROME	0.00641026	1.835664045295822
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.00641026	1.835664045295822
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.00641026	1.835664045295822
CONGENITAL LIPOMATOUS OVERGROWTH, VASCULAR MALFORMATIONS, AND EPIDERMAL NEVI	0.00641026	1.835664045295822
OCULOCEREBROCUTANEOUS SYNDROME	0.00641026	1.835664045295822
48,XXYY SYNDROME	0.00641026	1.835664045295822
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 3	0.00641026	1.835664045295822
FEINGOLD SYNDROME 1; FGLDS1	0.00641026	1.835664045295822
DUBOWITZ SYNDROME	0.00641026	1.835664045295822
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.00641026	1.835664045295822
HYPERTRICHOSIS CUBITI	0.00641026	1.835664045295822
X-LINKED INTELLECTUAL DISABILITY, MILES-CARPENTER TYPE	0.00641026	1.835664045295822
GABRIELE-DE VRIES SYNDROME	0.00641026	1.835664045295822
TEMTAMY SYNDROME	0.00641026	1.835664045295822
PROGRESSIVE HEMIFACIAL ATROPHY	0.00641026	1.835664045295822
CORNELIA DE LANGE SYNDROME 3	0.00641026	1.835664045295822
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.00641026	1.835664045295822
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.00641026	1.835664045295822
OCULOECTODERMAL SYNDROME; OES	0.00641026	1.835664045295822
EHLERS-DANLOS SYNDROME, AUTOSOMAL DOMINANT, TYPE UNSPECIFIED	0.00641026	1.835664045295822
KLEEFSTRA SYNDROME	0.00641026	1.835664045295822
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.00641026	1.835664045295822
TETRASOMY 18P	0.00641026	1.835664045295822
TRIOPIA	0.00641026	1.835664045295822
LAMB-SHAFFER SYNDROME	0.00641026	1.835664045295822
DEAFNESS-CRANIOFACIAL SYNDROME	0.00641026	1.835664045295822
LINEAR NEVUS SEBACEUS SYNDROME	0.00641026	1.835664045295822
WILDERVANCK SYNDROME	0.00641026	1.835664045295822
ISOLATED PLAGIOCEPHALY	0.00641026	1.835664045295822
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.00641026	1.835664045295822
2Q32Q33 MICRODELETION SYNDROME	0.00641026	1.835664045295822
2Q31.1 MICRODELETION SYNDROME	0.00641026	1.835664045295822
AICARDI SYNDROME; AIC	0.00641026	1.835664045295822
CRANIOFRONTONASAL SYNDROME; CFNS	0.00641026	1.835664045295822
MELNICK-NEEDLES SYNDROME	0.00641026	1.835664045295822
FAMILIAL LAMBDOID SYNOSTOSIS	0.00641026	1.835664045295822
MULTIPLE SYNOSTOSES SYNDROME	0.00641026	1.835664045295822
OROFACIODIGITAL SYNDROME TYPE 1	0.00641026	1.835664045295822
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.00641026	1.835664045295822
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.00641026	1.835664045295822
HYPOGLOSSIA-HYPODACTYLY SYNDROME	0.00641026	1.835664045295822
DELAYED SPEECH-FACIAL ASYMMETRY-STRABISMUS-EAR LOBE CREASES SYNDROME	0.00641026	1.835664045295822
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.00641026	1.835664045295822
PHAKOMATOSIS PIGMENTOVASCULARIS	0.00641026	1.835664045295822
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.00641026	1.835664045295822
48,XXXY SYNDROME	0.00641026	1.835664045295822
WIEDEMANN-STEINER SYNDROME	0.00641026	1.835664045295822
3Q29 MICRODELETION SYNDROME	0.00641026	1.835664045295822
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	0.00641026	1.835664045295822
OTOFACIOCERVICAL SYNDROME	0.00641026	1.835664045295822
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.00641026	1.835664045295822
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.00641026	1.835664045295822
DISTAL MONOSOMY 10Q	0.00641026	1.835664045295822
FOCAL DERMAL HYPOPLASIA; FDH	0.00641026	1.835664045295822
VELO-FACIAL-SKELETAL SYNDROME	0.00641026	1.835664045295822
GORDON SYNDROME	0.00641026	1.835664045295822
SCLEROSTEOSIS 2; SOST2	0.00641026	1.835664045295822
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.00641026	1.835664045295822
OROFACIODIGITAL SYNDROME I; OFD1	0.00641026	1.835664045295822
JOHNSON NEUROECTODERMAL SYNDROME	0.00641026	1.835664045295822
CHROMOSOME 17Q12 DELETION SYNDROME	0.00641026	1.835664045295822
TORTICOLLIS, KELOIDS, CRYPTORCHIDISM, AND RENAL DYSPLASIA; TKCR	0.00641026	1.835664045295822
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.00641026	1.835664045295822
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.00641026	1.835664045295822
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00641026	1.835664045295822
ZTTK SYNDROME; ZTTKS	0.00641026	1.835664045295822
BLEPHAROCHEILODONTIC SYNDROME 2; BCDS2	0.00641026	1.835664045295822
HEMIFACIAL HYPERPLASIA	0.00641026	1.835664045295822
JACOBSEN SYNDROME	0.00641026	1.835664045295822
MALAN OVERGROWTH SYNDROME	0.00641026	1.835664045295822
GABRIELE-DE VRIES SYNDROME; GADEVS	0.00641026	1.835664045295822
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.00641026	1.835664045295822
HYPOGONADOTROPIC HYPOGONADISM 1 WITH OR WITHOUT ANOSMIA; HH1	0.00641026	1.835664045295822
15Q24 MICRODELETION SYNDROME	0.00641026	1.835664045295822
ISOLATED KLIPPEL-FEIL SYNDROME	0.00641026	1.835664045295822
SCHEIE SYNDROME	0.0062431	1.7877955342195706
FOUNTAIN SYNDROME	0.0062431	1.7877955342195706
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.0062431	1.7877955342195706
SMITH-LEMLI-OPITZ SYNDROME	0.0062431	1.7877955342195706
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.0062431	1.7877955342195706
FG SYNDROME TYPE 1	0.0062431	1.7877955342195706
BILATERAL POLYMICROGYRIA	0.0062431	1.7877955342195706
MONOSOMY 18Q	0.0062431	1.7877955342195706
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.0062431	1.7877955342195706
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.0062431	1.7877955342195706
ZIMMERMANN-LABAND SYNDROME	0.0062431	1.7877955342195706
WILLIAMS SYNDROME	0.0062431	1.7877955342195706
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.0062431	1.7877955342195706
COFFIN-LOWRY SYNDROME	0.0062431	1.7877955342195706
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.0062431	1.7877955342195706
PETTIGREW SYNDROME	0.0062431	1.7877955342195706
VIPOMA	0.00621118	1.7786548135115428
ACROMEGALY	0.00621118	1.7786548135115428
RCAD (RENAL CYSTS AND DIABETES)	0.00621118	1.7786548135115428
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.00621118	1.7786548135115428
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1	0.00621118	1.7786548135115428
GLUCAGONOMA	0.00621118	1.7786548135115428
NEUROTROPHIC KERATOPATHY	0.00621118	1.7786548135115428
BARDET-BIEDL SYNDROME 1; BBS1	0.00621118	1.7786548135115428
CUSHING SYNDROME DUE TO ECTOPIC ACTH SECRETION	0.00621118	1.7786548135115428
HYPERLIPOPROTEINEMIA, TYPE V	0.00621118	1.7786548135115428
12Q14 MICRODELETION SYNDROME	0.00621118	1.7786548135115428
ACTH-DEPENDENT CUSHING SYNDROME	0.00621118	1.7786548135115428
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.00621118	1.7786548135115428
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.00621118	1.7786548135115428
PRADER-WILLI SYNDROME	0.00621118	1.7786548135115428
SOMATOSTATINOMA	0.00621118	1.7786548135115428
ALANINURIA WITH MICROCEPHALY, DWARFISM, ENAMEL HYPOPLASIA, AND DIABETES MELLITUS	0.00621118	1.7786548135115428
144800 HYPEROSTOSIS FRONTALIS INTERNA;;MORGAGNI-STEWART-MOREL SYNDROME	0.00621118	1.7786548135115428
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.00621118	1.7786548135115428
INSULINOMATOSIS AND DIABETES MELLITUS; INSDM	0.00621118	1.7786548135115428
CUSHING DISEASE	0.00621118	1.7786548135115428
ACTH-INDEPENDENT CUSHING SYNDROME	0.00621118	1.7786548135115428
FRIEDREICH ATAXIA	0.00621118	1.7786548135115428
FAMILIAL PARTIAL LIPODYSTROPHY, KÖBBERLING TYPE	0.00621118	1.7786548135115428
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT 2; ADCAD2	0.00621118	1.7786548135115428
EDEMA, FAMILIAL IDIOPATHIC, PREPUBERTAL	0.00621118	1.7786548135115428
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3; CGL3	0.00621118	1.7786548135115428
DIABETES MELLITUS, KETOSIS-PRONE; KPD	0.00621118	1.7786548135115428
DIABETES MELLITUS, INSULIN-DEPENDENT, 2	0.00621118	1.7786548135115428
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.00621118	1.7786548135115428
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.00621118	1.7786548135115428
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.00621118	1.7786548135115428
MEHMO SYNDROME	0.00621118	1.7786548135115428
167755 PANCREAS, DORSAL, AGENESIS OF	0.00621118	1.7786548135115428
PANCREATITIS, HEREDITARY	0.00621118	1.7786548135115428
AFRICAN IRON OVERLOAD	0.00621118	1.7786548135115428
MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 11	0.00621118	1.7786548135115428
WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT; WFSL	0.00621118	1.7786548135115428
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.00621118	1.7786548135115428
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.00621118	1.7786548135115428
LEPTIN RECEPTOR DEFICIENCY; LEPRD	0.00621118	1.7786548135115428
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.00621118	1.7786548135115428
MUSCULAR ATROPHY, ATAXIA, RETINITIS PIGMENTOSA, AND DIABETES MELLITUS	0.00621118	1.7786548135115428
MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 14; MODY14	0.00621118	1.7786548135115428
ATAXIA WITH VITAMIN E DEFICIENCY	0.00621118	1.7786548135115428
HEMOCHROMATOSIS TYPE 2	0.00621118	1.7786548135115428
STIFF-PERSON SYNDROME; SPS	0.00621118	1.7786548135115428
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.00621118	1.7786548135115428
FAMILIAL PANCREATIC CARCINOMA	0.00621118	1.7786548135115428
H SYNDROME	0.00621118	1.7786548135115428
BARDET-BIEDL SYNDROME 2	0.00621118	1.7786548135115428
ACUTE RESPIRATORY CORONAVIRUS INFECTION	0.00621118	1.7786548135115428
DIABETES MELLITUS, INSULIN-DEPENDENT; IDDM	0.00621118	1.7786548135115428
DYSTROPHIA MYOTONICA 2	0.00621118	1.7786548135115428
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.00621118	1.7786548135115428
BETA-THALASSEMIA MAJOR	0.00621118	1.7786548135115428
BETA-THALASSEMIA INTERMEDIA	0.00621118	1.7786548135115428
DYSBETALIPOPROTEINEMIA	0.00621118	1.7786548135115428
WOLFRAM-LIKE SYNDROME	0.00621118	1.7786548135115428
DYSKERATOSIS CONGENITA	0.00621118	1.7786548135115428
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 6; FPLD6	0.00621118	1.7786548135115428
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.00621118	1.7786548135115428
AICARDI-GOUTIÈRES SYNDROME	0.00621118	1.7786548135115428
FAMILIAL PARTIAL LIPODYSTROPHY, DUNNIGAN TYPE	0.00621118	1.7786548135115428
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.00621118	1.7786548135115428
ACERULOPLASMINEMIA	0.00621118	1.7786548135115428
IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED; IPEX	0.00621118	1.7786548135115428
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.00621118	1.7786548135115428
CUSHING SYNDROME DUE TO MACRONODULAR ADRENAL HYPERPLASIA	0.00621118	1.7786548135115428
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I	0.00621118	1.7786548135115428
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.00621118	1.7786548135115428
OSSIFICATION OF THE POSTERIOR LONGITUDINAL LIGAMENT OF SPINE; OPLL	0.00621118	1.7786548135115428
PRIMARY PIGMENTED NODULAR ADRENOCORTICAL DISEASE	0.00621118	1.7786548135115428
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.00621118	1.7786548135115428
DIABETES MELLITUS, INSULIN-DEPENDENT, 10	0.00621118	1.7786548135115428
FAMILIAL CHYLOMICRONEMIA SYNDROME	0.00621118	1.7786548135115428
JUVENILE-ONSET DIABETES MELLITUS-CENTRAL AND PERIPHERAL NEURODEGENERATION SYNDROME	0.00621118	1.7786548135115428
DIABETES MELLITUS, INSULIN-DEPENDENT, 6	0.00621118	1.7786548135115428
ACERULOPLASMINEMIA	0.00621118	1.7786548135115428
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.00621118	1.7786548135115428
EPIDERMOLYSIS BULLOSA ACQUISITA	0.00621118	1.7786548135115428
SYMPTOMATIC FORM OF HEMOCHROMATOSIS TYPE 1	0.00621118	1.7786548135115428
%601666 DIABETES MELLITUS, INSULIN-DEPENDENT, 15; IDDM15;;INSULIN-DEPENDENT DIABETES MELLITUS 15	0.00621118	1.7786548135115428
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.00621118	1.7786548135115428
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.00621118	1.7786548135115428
GOOD SYNDROME	0.00621118	1.7786548135115428
BARDET-BIEDL SYNDROME 6; BBS6	0.00621118	1.7786548135115428
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.00621118	1.7786548135115428
WERNER SYNDROME; WRN	0.00621118	1.7786548135115428
AUTOSOMAL SEMI-DOMINANT SEVERE LIPODYSTROPHIC LAMINOPATHY	0.00621118	1.7786548135115428
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.00621118	1.7786548135115428
PAROXYSMAL HEMICRANIA	0.00621118	1.7786548135115428
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.00621118	1.7786548135115428
HEREDITARY CHRONIC PANCREATITIS	0.00621118	1.7786548135115428
POEMS SYNDROME	0.00621118	1.7786548135115428
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.00621118	1.7786548135115428
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.00621118	1.7786548135115428
ADRENOCORTICAL CARCINOMA	0.00621118	1.7786548135115428
POLAND SYNDROME	0.00621118	1.7786548135115428
SPLENOPORTAL VASCULAR ANOMALIES	0.00621118	1.7786548135115428
BULLOUS PEMPHIGOID	0.00621118	1.7786548135115428
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.00621118	1.7786548135115428
ALEXANDER DISEASE	0.00621118	1.7786548135115428
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.00621118	1.7786548135115428
SOMATOMAMMOTROPINOMA	0.00621118	1.7786548135115428
ERYTHROKERATODERMIA VARIABILIS	0.00621118	1.7786548135115428
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00621118	1.7786548135115428
CYSTINOSIS, NEPHROPATHIC; CTNS	0.00621118	1.7786548135115428
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.00621118	1.7786548135115428
17Q12 MICRODELETION SYNDROME	0.00621118	1.7786548135115428
CRANIAL NERVES, RECURRENT PARESIS OF	0.00621118	1.7786548135115428
LYMPHEDEMA-DISTICHIASIS SYNDROME	0.00621118	1.7786548135115428
PREAXIAL HALLUCAL POLYDACTYLY	0.00621118	1.7786548135115428
PRIMROSE SYNDROME; PRIMS	0.00621118	1.7786548135115428
CUSHING SYNDROME	0.00621118	1.7786548135115428
MT-ATP6-RELATED MITOCHONDRIAL SPASTIC PARAPLEGIA	0.00621118	1.7786548135115428
STIFF PERSON SYNDROME AND RELATED DISORDERS	0.00621118	1.7786548135115428
PERIPARTUM CARDIOMYOPATHY	0.00621118	1.7786548135115428
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.00529164	1.5153321844432495
NEONATAL ADRENOLEUKODYSTROPHY	0.00529164	1.5153321844432495
HYPERLEUCINE-ISOLEUCINEMIA	0.00529164	1.5153321844432495
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.00529164	1.5153321844432495
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00529164	1.5153321844432495
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.00529164	1.5153321844432495
REFSUM DISEASE	0.00529164	1.5153321844432495
16P12.1P12.3 TRIPLICATION SYNDROME	0.00473934	1.3571736616661882
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.00473934	1.3571736616661882
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00473934	1.3571736616661882
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.00473934	1.3571736616661882
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.00473934	1.3571736616661882
X-LINKED DOMINANT CHONDRODYSPLASIA, CHASSAING-LACOMBE TYPE	0.00473934	1.3571736616661882
TRISOMY 17P	0.00473934	1.3571736616661882
PMM2-CDG	0.00473934	1.3571736616661882
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.00473934	1.3571736616661882
TRIPLOIDY	0.00473934	1.3571736616661882
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.00473934	1.3571736616661882
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.00473934	1.3571736616661882
DISTAL TRISOMY 17Q	0.00473934	1.3571736616661882
COFFIN-SIRIS SYNDROME 5	0.00473934	1.3571736616661882
SCHINZEL-GIEDION SYNDROME	0.00473934	1.3571736616661882
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00473934	1.3571736616661882
AICA-RIBOSIDURIA	0.00473934	1.3571736616661882
MOSAIC TRISOMY 14	0.00473934	1.3571736616661882
SEVERE OCULO-RENAL-CEREBELLAR SYNDROME	0.00473934	1.3571736616661882
SPONDYLOEPIPHYSEAL DYSPLASIA, CANTU TYPE	0.00473934	1.3571736616661882
AUTOSOMAL RECESSIVE FACIODIGITOGENITAL SYNDROME	0.00473934	1.3571736616661882
PITT-HOPKINS SYNDROME	0.00473934	1.3571736616661882
ANGELMAN SYNDROME	0.00473934	1.3571736616661882
1P21.3 MICRODELETION SYNDROME	0.00473934	1.3571736616661882
COFFIN-SIRIS SYNDROME	0.00473934	1.3571736616661882
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.00473934	1.3571736616661882
FRANK-TER HAAR SYNDROME	0.00473934	1.3571736616661882
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.00473934	1.3571736616661882
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.00473934	1.3571736616661882
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA, CANTU TYPE	0.00473934	1.3571736616661882
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.00473934	1.3571736616661882
DISTAL MONOSOMY 7Q36	0.00473934	1.3571736616661882
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.00473934	1.3571736616661882
CRANIOFRONTONASAL DYSPLASIA-POLAND ANOMALY SYNDROME	0.00473934	1.3571736616661882
ATYPICAL RETT SYNDROME	0.00473934	1.3571736616661882
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.00473934	1.3571736616661882
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.00473934	1.3571736616661882
2Q23.1 MICRODUPLICATION SYNDROME	0.00473934	1.3571736616661882
MUCOPOLYSACCHARIDOSIS TYPE 4	0.00473934	1.3571736616661882
DUPLICATION OF THE PITUITARY GLAND	0.00473934	1.3571736616661882
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.00473934	1.3571736616661882
NAGER SYNDROME	0.00473934	1.3571736616661882
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.00473934	1.3571736616661882
HALL-RIGGS SYNDROME	0.00473934	1.3571736616661882
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.00473934	1.3571736616661882
COFFIN-SIRIS SYNDROME 10; CSS10	0.00473934	1.3571736616661882
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.00473934	1.3571736616661882
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.00473934	1.3571736616661882
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.00473934	1.3571736616661882
19Q13.11 MICRODELETION SYNDROME	0.00473934	1.3571736616661882
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.00473934	1.3571736616661882
VERVERI-BRADY SYNDROME; VERBRAS	0.00473934	1.3571736616661882
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.00473934	1.3571736616661882
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.00473934	1.3571736616661882
FRYNS SYNDROME	0.00473934	1.3571736616661882
CEREBROFACIOTHORACIC DYSPLASIA	0.00473934	1.3571736616661882
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.00473934	1.3571736616661882
FRYNS-SMEETS-THIRY SYNDROME	0.00473934	1.3571736616661882
FLOATING-HARBOR SYNDROME	0.00473934	1.3571736616661882
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.00473934	1.3571736616661882
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.00473934	1.3571736616661882
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.00473934	1.3571736616661882
FETAL HYDANTOIN SYNDROME	0.00473934	1.3571736616661882
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.00473934	1.3571736616661882
17P11.2 MICRODUPLICATION SYNDROME	0.00473934	1.3571736616661882
ACROMELIC FRONTONASAL DYSPLASIA	0.00473934	1.3571736616661882
DUBOWITZ SYNDROME	0.00473934	1.3571736616661882
BARBER-SAY SYNDROME	0.00473934	1.3571736616661882
SSR4-CDG	0.00473934	1.3571736616661882
SMITH-FINEMAN-MYERS SYNDROME	0.00473934	1.3571736616661882
CHUDLEY-LOWRY-HOAR SYNDROME	0.00473934	1.3571736616661882
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00473934	1.3571736616661882
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.00473934	1.3571736616661882
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.00473934	1.3571736616661882
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.00473934	1.3571736616661882
ABLEPHARON MACROSTOMIA SYNDROME	0.00473934	1.3571736616661882
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.00473934	1.3571736616661882
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.00473934	1.3571736616661882
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.00473934	1.3571736616661882
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.00473934	1.3571736616661882
TEMPLE-BARAITSER SYNDROME	0.00473934	1.3571736616661882
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.00473934	1.3571736616661882
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.00473934	1.3571736616661882
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.00473934	1.3571736616661882
COFFIN-SIRIS SYNDROME 7; CSS7	0.00473934	1.3571736616661882
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.00473934	1.3571736616661882
TRANSALDOLASE DEFICIENCY	0.00473934	1.3571736616661882
FRYNS SYNDROME; FRNS	0.00473934	1.3571736616661882
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.00473934	1.3571736616661882
MORQUIO SYNDROME A	0.00473934	1.3571736616661882
ZUNICH NEUROECTODERMAL SYNDROME	0.00473934	1.3571736616661882
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.00473934	1.3571736616661882
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.00473934	1.3571736616661882
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.00473934	1.3571736616661882
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00473934	1.3571736616661882
TEMPLE-BARAITSER SYNDROME; TMBTS	0.00473934	1.3571736616661882
BARAITSER-WINTER SYNDROME 2; BRWS2	0.00473934	1.3571736616661882
WARSAW BREAKAGE SYNDROME; WABS	0.00473934	1.3571736616661882
COFFIN-SIRIS SYNDROME 2; CSS2	0.00473934	1.3571736616661882
FLOATING-HARBOR SYNDROME	0.00473934	1.3571736616661882
COFFIN-SIRIS SYNDROME 3; CSS3	0.00473934	1.3571736616661882
COFFIN-SIRIS SYNDROME 4; CSS4	0.00473934	1.3571736616661882
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.00473934	1.3571736616661882
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.00473934	1.3571736616661882
BARBER-SAY SYNDROME; BBRSAY	0.00473934	1.3571736616661882
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.00473934	1.3571736616661882
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.00473934	1.3571736616661882
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.00473934	1.3571736616661882
TEEBI-SHALTOUT SYNDROME; TBSH	0.00473934	1.3571736616661882
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.00473934	1.3571736616661882
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	0.00473934	1.3571736616661882
NOONAN SYNDROME 5; NS5	0.00473934	1.3571736616661882
STROMME SYNDROME; STROMS	0.00473934	1.3571736616661882
ARIMA SYNDROME	0.00473934	1.3571736616661882
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.00473934	1.3571736616661882
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.00473934	1.3571736616661882
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.00473934	1.3571736616661882
POTOCKI-LUPSKI SYNDROME	0.00473934	1.3571736616661882
MENTAL RETARDATION, X-LINKED 103	0.00473934	1.3571736616661882
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.00473934	1.3571736616661882
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.00473934	1.3571736616661882
TRICHOTHIODYSTROPHY 5, NONPHOTOSENSITIVE	0.00473934	1.3571736616661882
FACIOCARDIOMELIC SYNDROME	0.00473934	1.3571736616661882
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.00473934	1.3571736616661882
MANDIBULOFACIAL DYSOSTOSIS WITH MENTAL RETARDATION	0.00473934	1.3571736616661882
MECKEL SYNDROME, TYPE 1; MKS1	0.00473934	1.3571736616661882
FRANK-TER HAAR SYNDROME; FTHS	0.00473934	1.3571736616661882
MENTAL RETARDATION, BUENOS AIRES TYPE	0.00473934	1.3571736616661882
C SYNDROME	0.00473934	1.3571736616661882
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.00473934	1.3571736616661882
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00473934	1.3571736616661882
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.00473934	1.3571736616661882
RAINE SYNDROME	0.00473934	1.3571736616661882
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.00473934	1.3571736616661882
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.00473934	1.3571736616661882
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.00473934	1.3571736616661882
ANGELMAN SYNDROME	0.00473934	1.3571736616661882
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.00473934	1.3571736616661882
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00473934	1.3571736616661882
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.00473934	1.3571736616661882
TRICHOHEPATOENTERIC SYNDROME 1	0.00473934	1.3571736616661882
ALAZAMI SYNDROME; ALAZS	0.00473934	1.3571736616661882
HELSMOORTEL-VAN DER AA SYNDROME	0.00473934	1.3571736616661882
MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA	0.00473934	1.3571736616661882
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.00473934	1.3571736616661882
ADENYLOSUCCINASE DEFICIENCY	0.00473934	1.3571736616661882
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.00473934	1.3571736616661882
COACH SYNDROME	0.00473934	1.3571736616661882
DELETED IN AZOOSPERMIA	0.00378788	1.0847103118898667
DERMATOLEUKODYSTROPHY	0.00378788	1.0847103118898667
XM SYSTEM	0.00378788	1.0847103118898667
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.00378788	1.0847103118898667
238800 HYPERMETABOLISM DUE TO DEFECT IN MITOCHONDRIA	0.00378788	1.0847103118898667
PROPERDIN DEFICIENCY, X-LINKED	0.00378788	1.0847103118898667
HOOFT DISEASE	0.00378788	1.0847103118898667
PREMATURE OVARIAN FAILURE 1	0.00378788	1.0847103118898667
SALLA DISEASE	0.00378788	1.0847103118898667
PITUITARY DWARFISM IV	0.00378788	1.0847103118898667
DERMATITIS, ATOPIC	0.00378788	1.0847103118898667
HYPOASCORBEMIA	0.00378788	1.0847103118898667
GONADOBLASTOMA	0.00378788	1.0847103118898667
MACULAR DYSTROPHY, CORNEAL, 1	0.00378788	1.0847103118898667
SPERMATOGENIC FAILURE, X-LINKED, 2; SPGFX2	0.00378788	1.0847103118898667
LUTHERAN SUPPRESSOR, X-LINKED	0.00378788	1.0847103118898667
ICHTHYOSIS AND MALE HYPOGONADISM	0.00378788	1.0847103118898667
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.00378788	1.0847103118898667
ICHTHYOSIS, X-LINKED	0.00378788	1.0847103118898667
GRANULOMAS, CONGENITAL CEREBRAL	0.00378788	1.0847103118898667
MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS, X-LINKED	0.00378788	1.0847103118898667
46,XX GONADAL DYSGENESIS	0.00378788	1.0847103118898667
X-LINKED ADRENOLEUKODYSTROPHY	0.00378788	1.0847103118898667
ERYTHROCYTOSIS, FAMILIAL, 8; ECYT8	0.00378788	1.0847103118898667
ETHANOLAMINOSIS	0.00378788	1.0847103118898667
SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL	0.00378788	1.0847103118898667
NEURONAL CEROID LIPOFUSCINOSIS	0.00378788	1.0847103118898667
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.00378788	1.0847103118898667
EHLERS-DANLOS SYNDROME, TYPE VI	0.00378788	1.0847103118898667
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.00378788	1.0847103118898667
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.00378788	1.0847103118898667
HYPOGONADOTROPIC HYPOGONADISM 24 WITHOUT ANOSMIA; HH24	0.00378788	1.0847103118898667
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 1; EV1	0.00378788	1.0847103118898667
EPILEPSY-TELANGIECTASIA	0.00378788	1.0847103118898667
FETAL IODINE DEFICIENCY DISORDER	0.00378788	1.0847103118898667
SHORT STATURE SYNDROME, BRUSSELS TYPE	0.00378788	1.0847103118898667
SCHIZOPHRENIA 4	0.00378788	1.0847103118898667
HYPOGONADOTROPIC HYPOGONADISM 23 WITHOUT ANOSMIA; HH23	0.00378788	1.0847103118898667
NEURONAL INTESTINAL DYSPLASIA, TYPE B	0.00378788	1.0847103118898667
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.00378788	1.0847103118898667
601195 IRON OVERLOAD IN AFRICA;;AFRICAN IRON OVERLOAD;;BANTU SIDEROSIS	0.00378788	1.0847103118898667
LISSENCEPHALY TYPE III AND BONE DYSPLASIA	0.00378788	1.0847103118898667
NEURAL TUBE DEFECTS, FOLATE-SENSITIVE	0.00378788	1.0847103118898667
CONE-ROD DYSTROPHY 1; CORD1	0.00378788	1.0847103118898667
GLUTATHIONURIA	0.00378788	1.0847103118898667
600459 ARTERIAL DISSECTION WITH LENTIGINOSIS	0.00378788	1.0847103118898667
CUTIS LAXA	0.00378788	1.0847103118898667
LACTOSE INTOLERANCE, ADULT TYPE	0.00378788	1.0847103118898667
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00378788	1.0847103118898667
ONCOCYTOMA	0.00378788	1.0847103118898667
GAPO SYNDROME; GAPOS	0.00378788	1.0847103118898667
MACROCYTOSIS, FAMILIAL	0.00378788	1.0847103118898667
DOPAMINE BETA-HYDROXYLASE, PLASMA, THERMOLABILITY OF	0.00378788	1.0847103118898667
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.00378788	1.0847103118898667
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.00378788	1.0847103118898667
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.00378788	1.0847103118898667
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.00378788	1.0847103118898667
600333 MOTOR NEURON DISEASE WITH DEMENTIA AND OPHTHALMOPLEGIA	0.00378788	1.0847103118898667
GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUETO	0.00378788	1.0847103118898667
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.00378788	1.0847103118898667
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.00378788	1.0847103118898667
SERTOLI CELL-ONLY SYNDROME	0.00378788	1.0847103118898667
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.00378788	1.0847103118898667
FINGERPRINT BODY MYOPATHY	0.00378788	1.0847103118898667
SODIUM-POTASSIUM-ATPASE ACTIVITY OF RED CELL	0.00378788	1.0847103118898667
NEUTROPHIL ACTIN DYSFUNCTION	0.00378788	1.0847103118898667
PYRIDOXINE-DEPENDENT EPILEPSY	0.00378788	1.0847103118898667
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.00378788	1.0847103118898667
SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	0.00378788	1.0847103118898667
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.00378788	1.0847103118898667
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.00378788	1.0847103118898667
ASPLENIA, ISOLATED CONGENITAL; ICAS	0.00378788	1.0847103118898667
256720 NEUROLOGIC DISEASE, INFANTILE MULTISYSTEM, WITH OSSEOUS FRAGILITY	0.00378788	1.0847103118898667
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.00378788	1.0847103118898667
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.00378788	1.0847103118898667
SUCROSURIA, HIATUS HERNIA AND MENTAL RETARDATION	0.00378788	1.0847103118898667
TESTICULAR GERM CELL TUMOR; TGCT	0.00378788	1.0847103118898667
THANATOPHORIC DYSPLASIA, GLASGOW VARIANT	0.00378788	1.0847103118898667
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.00378788	1.0847103118898667
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2A	0.00378788	1.0847103118898667
PENDRED SYNDROME	0.00378788	1.0847103118898667
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.00378788	1.0847103118898667
%257600 OCULAR MYOPATHY WITH CURARE SENSITIVITY	0.00378788	1.0847103118898667
DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES	0.00378788	1.0847103118898667
NEPHROSIALIDOSIS	0.00378788	1.0847103118898667
%270150 SJOGREN SYNDROME;;SICCA SYNDROME	0.00378788	1.0847103118898667
INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP	0.00378788	1.0847103118898667
LARON SYNDROME	0.00378788	1.0847103118898667
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.00378788	1.0847103118898667
PROGESTERONE RESISTANCE	0.00378788	1.0847103118898667
17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	0.00378788	1.0847103118898667
PSEUDOURIDINURIA AND MENTAL DEFECT	0.00378788	1.0847103118898667
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	0.00378788	1.0847103118898667
EPILEPSY, PYRIDOXINE-DEPENDENT	0.00378788	1.0847103118898667
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.00378788	1.0847103118898667
OSTEOGENIC SARCOMA	0.00378788	1.0847103118898667
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.00378788	1.0847103118898667
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.00378788	1.0847103118898667
SPERMATOGENIC FAILURE 1; SPGF1	0.00378788	1.0847103118898667
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.00378788	1.0847103118898667
REVESZ SYNDROME	0.00378788	1.0847103118898667
OCULORENOCEREBELLAR SYNDROME	0.00378788	1.0847103118898667
257960 OCULOTRICHODYSPLASIA; OTD	0.00378788	1.0847103118898667
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.00378788	1.0847103118898667
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.00378788	1.0847103118898667
CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN	0.00378788	1.0847103118898667
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00378788	1.0847103118898667
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.00378788	1.0847103118898667
MAGNESIUM, ELEVATED RED CELL	0.00378788	1.0847103118898667
COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING	0.00378788	1.0847103118898667
LYMPHOBLASTIC TRANSFORMATION, INTRINSIC DEFECT IN	0.00378788	1.0847103118898667
LYMPHOBLASTIC TRANSFORMATION, INHIBITION OF	0.00378788	1.0847103118898667
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.00378788	1.0847103118898667
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.00378788	1.0847103118898667
LIPASE DEFICIENCY, COMBINED	0.00378788	1.0847103118898667
245650 LARSEN-LIKE SYNDROME, LETHAL TYPE	0.00378788	1.0847103118898667
ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	0.00378788	1.0847103118898667
CALVARIAL HYPEROSTOSIS	0.00378788	1.0847103118898667
MICROCEPHALY-BRAIN DEFECT-SPASTICITY-HYPERNATREMIA SYNDROME	0.00378788	1.0847103118898667
ACETYLATION, SLOW	0.00378788	1.0847103118898667
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.00378788	1.0847103118898667
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00378788	1.0847103118898667
CONGENITAL ADRENAL HYPERPLASIA	0.00378788	1.0847103118898667
INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	0.00378788	1.0847103118898667
ALAND ISLAND EYE DISEASE	0.00378788	1.0847103118898667
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN BRANCHING ENZYME DEFICIENCY	0.00378788	1.0847103118898667
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.00378788	1.0847103118898667
METAPHYSEAL CHONDRODYSPLASIA, PENA TYPE	0.00378788	1.0847103118898667
TINEA IMBRICATA, SUSCEPTIBILITY TO	0.00378788	1.0847103118898667
CUTANEOUS COLLAGENOUS VASCULOPATHY	0.00378788	1.0847103118898667
T-SUBSTANCE ANOMALY	0.00378788	1.0847103118898667
MYOPATHY, GRANULOVACUOLAR LOBULAR, WITH ELECTRICAL MYOTONIA	0.00378788	1.0847103118898667
MYELOPEROXIDASE DEFICIENCY	0.00378788	1.0847103118898667
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.00378788	1.0847103118898667
MYASTHENIA, CONGENITAL, REFRACTORY TO ACETYLCHOLINESTERASE INHIBITORS	0.00378788	1.0847103118898667
XANTHINURIA, TYPE I	0.00378788	1.0847103118898667
MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS	0.00378788	1.0847103118898667
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00378788	1.0847103118898667
OSTEOMESOPYKNOSIS	0.00378788	1.0847103118898667
XYLOSIDASE DEFICIENCY	0.00378788	1.0847103118898667
%253240 MUCUS INSPISSATION OF RESPIRATORY TRACT	0.00378788	1.0847103118898667
MITOCHONDRIAL MYOPATHY WITH A DEFECT IN MITOCHONDRIAL-PROTEIN TRANSPORT	0.00378788	1.0847103118898667
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.00378788	1.0847103118898667
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.00378788	1.0847103118898667
METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA; METAG	0.00378788	1.0847103118898667
LYMPHOKINE DEFICIENCY	0.00378788	1.0847103118898667
PLATELET PROSTACYCLIN RECEPTOR DEFECT	0.00378788	1.0847103118898667
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1; AHMIO1	0.00378788	1.0847103118898667
ALPHA-2-DEFICIENT COLLAGEN DISEASE	0.00378788	1.0847103118898667
VERTEBRAL FUSION, POSTERIOR LUMBOSACRAL, WITH BLEPHAROPTOSIS	0.00378788	1.0847103118898667
%193090 TRANSCOBALAMIN I DEFICIENCY;;TCN1 DEFICIENCY;;COBALAMIN PSEUDODEFICIENCY DUE TO TRANSCOBALAMIN DEFICIENCY;;COBALAMIN R BINDER PROTEIN DEFICIENCYTRANSCOBALAMIN I DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED;;R BINDER DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED	0.00378788	1.0847103118898667
WHITE SPONGE NEVUS OF CANNON	0.00378788	1.0847103118898667
THIOPURINE S-METHYLTRANSFERASE DEFICIENCY	0.00378788	1.0847103118898667
HEINZ BODY ANEMIAS	0.00378788	1.0847103118898667
GLUTATHIONE REDUCTASE	0.00378788	1.0847103118898667
ZINC, ELEVATED PLASMA	0.00378788	1.0847103118898667
GLOMUVENOUS MALFORMATIONS	0.00378788	1.0847103118898667
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.00378788	1.0847103118898667
ADRENAL HYPOPLASIA, CONGENITAL, WITH ABSENT PITUITARY LUTEINIZINGHORMONE	0.00378788	1.0847103118898667
ALKAPTONURIA	0.00378788	1.0847103118898667
AMOBARBITAL, DEFICIENT N-HYDROXYLATION OF	0.00378788	1.0847103118898667
PREMATURE CENTROMERE DIVISION; PCD	0.00378788	1.0847103118898667
ANEMIA, AUTOIMMUNE HEMOLYTIC	0.00378788	1.0847103118898667
FLOOD FACTOR DEFICIENCY	0.00378788	1.0847103118898667
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, ASSOCIATED WITH ABNORMALITY OF REDCELL MEMBRANE	0.00378788	1.0847103118898667
DRUG METABOLISM, POOR, CYP2D6-RELATEDDRUG METABOLISM, ULTRARAPID, CYP2D6-RELATED, INCLUDED	0.00378788	1.0847103118898667
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.00378788	1.0847103118898667
AREDYLD	0.00378788	1.0847103118898667
EPOXIDE HYDROLASE 1, MICROSOMAL	0.00378788	1.0847103118898667
TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN	0.00378788	1.0847103118898667
LARSEN-LIKE SYNDROME	0.00378788	1.0847103118898667
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.00378788	1.0847103118898667
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.00378788	1.0847103118898667
HYPERPROGLUCAGONEMIA	0.00378788	1.0847103118898667
OSTEOGENESIS IMPERFECTA, TYPE V	0.00378788	1.0847103118898667
VENTRICULAR TACHYCARDIA, FAMILIAL	0.00378788	1.0847103118898667
VASCULITIS, LYMPHOCYTIC, NODULAR	0.00378788	1.0847103118898667
OVARIAN CANCER	0.00378788	1.0847103118898667
PACMAN DYSPLASIA	0.00378788	1.0847103118898667
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00378788	1.0847103118898667
PERRY SYNDROME	0.00378788	1.0847103118898667
PARAOXONASE 1	0.00378788	1.0847103118898667
PELVIC LIPOMATOSIS WITH CROSSED RENAL ECTOPIA	0.00378788	1.0847103118898667
APOLIPOPROTEIN(A)	0.00378788	1.0847103118898667
NORMOKALEMIC PERIODIC PARALYSIS	0.00378788	1.0847103118898667
PHAGOCYTOSIS, PLASMA-RELATED DEFECT IN	0.00378788	1.0847103118898667
PSEUDOCHOLINESTERASE, INCREASE IN PLASMA LEVEL OF	0.00378788	1.0847103118898667
SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY	0.00378788	1.0847103118898667
MYOPATHY, SPHEROID BODY	0.00378788	1.0847103118898667
SPINAL ARACHNOIDITIS	0.00378788	1.0847103118898667
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 2	0.00378788	1.0847103118898667
SPONDYLOEPIPHYSEAL DYSPLASIA WITH PUNCTATE CORNEAL DYSTROPHY	0.00378788	1.0847103118898667
KERATOSIS, FAMILIAL ACTINIC	0.00378788	1.0847103118898667
POLYCYSTIC OVARY SYNDROME 1	0.00378788	1.0847103118898667
ICHTHYOSIS HYSTRIX, CURTH-MACKLIN TYPE	0.00378788	1.0847103118898667
BARTTER SYNDROME	0.00378788	1.0847103118898667
THYROID CANCER, NONMEDULLARY, 2; NMTC2	0.00378788	1.0847103118898667
TREMOR OF INTENTION, ATAXIA, AND LIPOFUSCINOSIS	0.00378788	1.0847103118898667
CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	0.00378788	1.0847103118898667
URATE-BINDING GLOBULIN, DECREASE IN	0.00378788	1.0847103118898667
CARDIAC LIPIDOSIS, FAMILIAL	0.00378788	1.0847103118898667
MYOTONIC MYOPATHY WITH CYLINDRICAL SPIRALS	0.00378788	1.0847103118898667
CEPHALIN LIPIDOSIS	0.00378788	1.0847103118898667
CEREBELLOPARENCHYMAL DISORDER V	0.00378788	1.0847103118898667
103230 ADRENOCORTICAL HYPOFUNCTION, CHRONIC PRIMARY CONGENITAL;;ADDISON DISEASE, CONGENITAL	0.00378788	1.0847103118898667
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.00378788	1.0847103118898667
MACULAR CORNEAL DYSTROPHY	0.00378788	1.0847103118898667
HEREDITARY HYPERFERRITINEMIA-CATARACT SYNDROME	0.00378788	1.0847103118898667
CITRULLINE TRANSPORT DEFECT	0.00378788	1.0847103118898667
BEETURIA	0.00378788	1.0847103118898667
BLOOD GROUP, DUFFY SYSTEM; FY	0.00378788	1.0847103118898667
CILIARY DISCOORDINATION DUE TO RANDOM CILIARY ORIENTATION	0.00378788	1.0847103118898667
CARBOXYLESTERASE 1	0.00378788	1.0847103118898667
CATECHOL-O-METHYLTRANSFERASE	0.00378788	1.0847103118898667
CHOROIDAL OSTEOMA, BILATERAL	0.00378788	1.0847103118898667
CORONARY ARTERY DISSECTION, SPONTANEOUS	0.00378788	1.0847103118898667
COUMARIN RESISTANCE	0.00378788	1.0847103118898667
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.00378788	1.0847103118898667
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.00378788	1.0847103118898667
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.00378788	1.0847103118898667
CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 2	0.00378788	1.0847103118898667
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.00150376	0.43062187255338236
DEAFNESS WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA	0.00150376	0.43062187255338236
ALBINISM-DEAFNESS SYNDROME	0.00150376	0.43062187255338236
BRITTLE CORNEA SYNDROME	0.00150376	0.43062187255338236
ACROCALLOSAL SYNDROME	0.00150376	0.43062187255338236
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.00150376	0.43062187255338236
ARTHROGRYPOSIS-LIKE HAND ANOMALY AND SENSORINEURAL DEAFNESS	0.00150376	0.43062187255338236
ADENOHYPOPHYSITIS	0.00150376	0.43062187255338236
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00150376	0.43062187255338236
STICKLER SYNDROME TYPE 1	0.00150376	0.43062187255338236
STICKLER SYNDROME TYPE 2	0.00150376	0.43062187255338236
DEAFNESS-VITILIGO-ACHALASIA SYNDROME	0.00150376	0.43062187255338236
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	0.00150376	0.43062187255338236
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.00150376	0.43062187255338236
STICKLER SYNDROME, TYPE I	0.00150376	0.43062187255338236
ACROCRANIOFACIAL DYSOSTOSIS	0.00150376	0.43062187255338236
HADDAD SYNDROME	0.00150376	0.43062187255338236
DEAFNESS-OLIGODONTIA SYNDROME	0.00150376	0.43062187255338236
NEURAMINIDASE DEFICIENCY	0.00150376	0.43062187255338236
ERMINE PHENOTYPE	0.00150376	0.43062187255338236
TRIPLE A SYNDROME	0.00150376	0.43062187255338236
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.00150376	0.43062187255338236
USHER SYNDROME	0.00150376	0.43062187255338236
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.00150376	0.43062187255338236
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.00150376	0.43062187255338236
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00150376	0.43062187255338236
SPLIT HAND/FOOT MALFORMATION 1 (SHFM1)	0.00150376	0.43062187255338236
HEARING LOSS-FAMILIAL SALIVARY GLAND INSENSITIVITY TO ALDOSTERONE SYNDROME	0.00150376	0.43062187255338236
WAARDENBURG SYNDROME TYPE 2	0.00150376	0.43062187255338236
DEAFNESS, MID-TONE NEURAL	0.00150376	0.43062187255338236
MACROTHROMBOCYTOPENIA AND GRANULOCYTE INCLUSIONS WITH OR WITHOUT NEPHRITIS OR SENSORINEURAL HEARING LOSS; MATINS	0.00150376	0.43062187255338236
SPINOCEREBELLAR ATAXIA TYPE 37	0.00150376	0.43062187255338236
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.00150376	0.43062187255338236
DEAFNESS-LYMPHEDEMA-LEUKEMIA SYNDROME	0.00150376	0.43062187255338236
DEAFNESS, CONGENITAL, AND ONYCHODYSTROPHY, AUTOSOMAL DOMINANT	0.00150376	0.43062187255338236
VON HIPPEL-LINDAU DISEASE	0.00150376	0.43062187255338236
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.00150376	0.43062187255338236
THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME	0.00150376	0.43062187255338236
256120 NEPHROPATHY, DEAFNESS, AND HYPERPARATHYROIDISM	0.00150376	0.43062187255338236
CORNELIA DE LANGE SYNDROME 1	0.00150376	0.43062187255338236
PAPILLORENAL SYNDROME	0.00150376	0.43062187255338236
WORSTER-DROUGHT SYNDROME	0.00150376	0.43062187255338236
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.00150376	0.43062187255338236
DISTAL MONOSOMY 19P13.3	0.00150376	0.43062187255338236
JUBERG-MARSIDI SYNDROME	0.00150376	0.43062187255338236
FRIEDREICH ATAXIA, SO-CALLED, WITH OPTIC ATROPHY AND SENSORINEURALDEAFNESS	0.00150376	0.43062187255338236
HURLER-SCHEIE SYNDROME	0.00150376	0.43062187255338236
ACRO-RENAL-OCULAR SYNDROME	0.00150376	0.43062187255338236
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.00150376	0.43062187255338236
NASODIGITOACOUSTIC SYNDROME	0.00150376	0.43062187255338236
VOGT-KOYANAGI-HARADA DISEASE	0.00150376	0.43062187255338236
PANHYPOPHYSITIS	0.00150376	0.43062187255338236
CRANIOFACIAL-DEAFNESS-HAND SYNDROME; CDHS	0.00150376	0.43062187255338236
LEIGH SYNDROME; LS	0.00150376	0.43062187255338236
NAIL-PATELLA SYNDROME	0.00150376	0.43062187255338236
HYPEROSTOSIS CORTICALIS GENERALISATA	0.00150376	0.43062187255338236
ABRUZZO-ERICKSON SYNDROME	0.00150376	0.43062187255338236
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP	0.00150376	0.43062187255338236
APHONIA-DEAFNESS-RETINAL DYSTROPHY-BIFID HALLUCES-INTELLECTUAL DISABILITY SYNDROME	0.00150376	0.43062187255338236
PROXIMAL SYMPHALANGISM	0.00150376	0.43062187255338236
HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DISEASE	0.00150376	0.43062187255338236
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 6	0.00150376	0.43062187255338236
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA WITH LATE-ONSET SPASTICITY	0.00150376	0.43062187255338236
DEAFNESS-INFERTILITY SYNDROME	0.00150376	0.43062187255338236
BRANCHIOOCULOFACIAL SYNDROME	0.00150376	0.43062187255338236
THYROCEREBRORENAL SYNDROME	0.00150376	0.43062187255338236
DEAFNESS, AUTOSOMAL DOMINANT 1	0.00150376	0.43062187255338236
HYPEROSTOSIS CRANIALIS INTERNA; HCIN	0.00150376	0.43062187255338236
ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL DOMINANT	0.00150376	0.43062187255338236
115250 COLLAGENOMA, FAMILIAL CUTANEOUS	0.00150376	0.43062187255338236
X-LINKED DOMINANT CHONDRODYSPLASIA PUNCTATA	0.00150376	0.43062187255338236
RENIER-GABREELS-JASPER SYNDROME	0.00150376	0.43062187255338236
XERODERMA PIGMENTOSUM	0.00150376	0.43062187255338236
SPINOCEREBELLAR ATAXIA 31	0.00150376	0.43062187255338236
OSTEOPENIA-MYOPIA-HEARING LOSS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.00150376	0.43062187255338236
ZELLWEGER SYNDROME	0.00150376	0.43062187255338236
COCKAYNE SYNDROME A; CSA	0.00150376	0.43062187255338236
KERATODERMA HEREDITARIUM MUTILANS WITH ICHTHYOSIS	0.00150376	0.43062187255338236
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.00150376	0.43062187255338236
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.00150376	0.43062187255338236
%223200 DISORGANIZATION, MOUSE, HOMOLOG OF;;DS	0.00150376	0.43062187255338236
KLIPPEL-FEIL SYNDROME, AUTOSOMAL RECESSIVE	0.00150376	0.43062187255338236
KERATODERMA HEREDITARIUM MUTILANS	0.00150376	0.43062187255338236
NEUROFIBROMATOSIS TYPE 2	0.00150376	0.43062187255338236
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.00150376	0.43062187255338236
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.00150376	0.43062187255338236
ECTODERMAL DYSPLASIA AND NEUROSENSORY DEAFNESS	0.00150376	0.43062187255338236
NOONAN SYNDROME	0.00150376	0.43062187255338236
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.00150376	0.43062187255338236
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.00150376	0.43062187255338236
KRABBE DISEASE	0.00150376	0.43062187255338236
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.00150376	0.43062187255338236
CEDNIK SYNDROME	0.00150376	0.43062187255338236
SENSORINEURAL HEARING LOSS-EARLY GRAYING-ESSENTIAL TREMOR SYNDROME	0.00150376	0.43062187255338236
KALLMANN SYNDROME	0.00150376	0.43062187255338236
KID SYNDROME	0.00150376	0.43062187255338236
ERMINE PHENOTYPE	0.00150376	0.43062187255338236
FAMILIAL COLD URTICARIA	0.00150376	0.43062187255338236
CEREBELLAR ATAXIA AND NEUROSENSORY DEAFNESS	0.00150376	0.43062187255338236
X-LINKED AGAMMAGLOBULINEMIA	0.00150376	0.43062187255338236
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.00150376	0.43062187255338236
ALPORT SYNDROME	0.00150376	0.43062187255338236
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, WITH DEAFNESS, MENTAL RETARDATION,AND ABSENT SENSORY LARGE MYELINATED FIBERS	0.00150376	0.43062187255338236
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IA; HSAN1A	0.00150376	0.43062187255338236
CONGENITAL MYASTHENIC SYNDROME	0.00150376	0.43062187255338236
FAMILIAL OR SPORADIC HEMIPLEGIC MIGRAINE	0.00150376	0.43062187255338236
CORNEAL DYSTROPHY AND PERCEPTIVE DEAFNESS	0.00150376	0.43062187255338236
MERRF	0.00150376	0.43062187255338236
MELAS	0.00150376	0.43062187255338236
MUCOPOLYSACCHARIDOSIS TYPE 1	0.00150376	0.43062187255338236
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.00150376	0.43062187255338236
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.00150376	0.43062187255338236
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.00150376	0.43062187255338236
ACUTE BILIRUBIN ENCEPHALOPATHY	0.00150376	0.43062187255338236
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.00150376	0.43062187255338236
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.00150376	0.43062187255338236
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.00150376	0.43062187255338236
DEAFNESS, NERVE TYPE, WITH MESENTERIC DIVERTICULA OF SMALL BOWEL ANDPROGRESSIVE SENSORY NEUROPATHY	0.00150376	0.43062187255338236
CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY-COLOBOMA-MICROGNATHIA SYNDROME	0.00150376	0.43062187255338236
DEAFNESS, NEURAL, CONGENITAL MODERATE	0.00150376	0.43062187255338236
DEAFNESS, NEURAL, WITH ATYPICAL ATOPIC DERMATITIS	0.00150376	0.43062187255338236
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.00150376	0.43062187255338236
DEAFNESS, SENSORINEURAL, WITH PITUITARY DWARFISM	0.00150376	0.43062187255338236
MUCOPOLYSACCHARIDOSIS TYPE 2	0.00150376	0.43062187255338236
CEREBELLAR ATAXIA WITH NEUROPATHY AND BILATERAL VESTIBULAR AREFLEXIA SYNDROME	0.00150376	0.43062187255338236
MULTIPLE SULFATASE DEFICIENCY	0.00150376	0.43062187255338236
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.00150376	0.43062187255338236
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.00150376	0.43062187255338236
PENDRED SYNDROME	0.00150376	0.43062187255338236
ATAXIA, DEAFNESS, AND CARDIOMYOPATHY	0.00150376	0.43062187255338236
3P25.3 MICRODELETION SYNDROME	0.00150376	0.43062187255338236
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.00150376	0.43062187255338236
STICKLER SYNDROME, TYPE III	0.00150376	0.43062187255338236
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE	0.00150376	0.43062187255338236
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.00150376	0.43062187255338236
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.00150376	0.43062187255338236
184000 SPONDYLOEPIPHYSEAL DYSPLASIA, MYOPIA, AND SENSORINEURAL DEAFNESS	0.00150376	0.43062187255338236
VICI SYNDROME; VICIS	0.00150376	0.43062187255338236
MARSHALL SYNDROME	0.00150376	0.43062187255338236
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.00150376	0.43062187255338236
SIALIDOSIS TYPE 1	0.00150376	0.43062187255338236
RICHARDS-RUNDLE SYNDROME; RRNS	0.00150376	0.43062187255338236
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.00150376	0.43062187255338236
STICKLER SYNDROME	0.00150376	0.43062187255338236
SUSAC SYNDROME	0.00150376	0.43062187255338236
HIRSCHSPRUNG DISEASE	0.00150376	0.43062187255338236
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.00150376	0.43062187255338236
OTODENTAL DYSPLASIA	0.00150376	0.43062187255338236
OCULOPHARYNGODISTAL MYOPATHY; OPDM	0.00150376	0.43062187255338236
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.00150376	0.43062187255338236
SALT-AND-PEPPER SYNDROME	0.00150376	0.43062187255338236
RETINITIS PIGMENTOSA	0.00150376	0.43062187255338236
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.00150376	0.43062187255338236
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.00150376	0.43062187255338236
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.00150376	0.43062187255338236
MICROPHTHALMIA, SYNDROMIC 3	0.00150376	0.43062187255338236
FOUNTAIN SYNDROME	0.00150376	0.43062187255338236
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.00150376	0.43062187255338236
DENTINOGENESIS IMPERFECTA-SHORT STATURE-HEARING LOSS-INTELLECTUAL DISABILITY SYNDROME	0.00150376	0.43062187255338236
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.00150376	0.43062187255338236
RADIO-ULNAR SYNOSTOSIS-AMEGAKARYOCYTIC THROMBOCYTOPENIA SYNDROME	0.00150376	0.43062187255338236
GALACTOSE EPIMERASE DEFICIENCY	0.00150376	0.43062187255338236
LEBER CONGENITAL AMAUROSIS, TYPE I	0.00150376	0.43062187255338236
RELAPSING POLYCHONDRITIS	0.00150376	0.43062187255338236
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.00150376	0.43062187255338236
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.00150376	0.43062187255338236
ACROCRANIOFACIAL DYSOSTOSIS	0.00150376	0.43062187255338236
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.00150376	0.43062187255338236
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.00150376	0.43062187255338236
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.00150376	0.43062187255338236
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.00150376	0.43062187255338236
FAMILIAL LONG QT SYNDROME	0.00150376	0.43062187255338236
PAGET DISEASE OF BONE 5, JUVENILE-ONSET	0.00150376	0.43062187255338236
INFANTILE REFSUM DISEASE	0.00150376	0.43062187255338236
WT LIMB-BLOOD SYNDROME	0.00150376	0.43062187255338236
221745 DEAFNESS, SENSORINEURAL, AUTOSOMAL-MITOCHONDRIAL TYPE	0.00150376	0.43062187255338236
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.00150376	0.43062187255338236
DEAFNESS-SMALL BOWEL DIVERTICULOSIS-NEUROPATHY SYNDROME	0.00150376	0.43062187255338236
DEAFNESS, AUTOSOMAL RECESSIVE 66; DFNB66	0.00150376	0.43062187255338236
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.00150376	0.43062187255338236
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 24	0.00150376	0.43062187255338236
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 27	0.00150376	0.43062187255338236
HUNTER-MACDONALD SYNDROME	0.00150376	0.43062187255338236
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2	0.00150376	0.43062187255338236
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.00150376	0.43062187255338236
ARTHROGRYPOSIS-LIKE HAND ANOMALY-SENSORINEURAL DEAFNESS SYNDROME	0.00150376	0.43062187255338236
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.00150376	0.43062187255338236
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.00150376	0.43062187255338236
ATAXIA-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00150376	0.43062187255338236
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.00150376	0.43062187255338236
BRACHYDACTYLY, TYPE B2	0.00150376	0.43062187255338236
AUTOSOMAL DOMINANT OPTIC ATROPHY PLUS SYNDROME	0.00150376	0.43062187255338236
BJÖRNSTAD SYNDROME	0.00150376	0.43062187255338236
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.00150376	0.43062187255338236
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.00150376	0.43062187255338236
AYMÉ-GRIPP SYNDROME	0.00150376	0.43062187255338236
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 5A	0.00150376	0.43062187255338236
MIDDLE EAR NEUROENDOCRINE TUMOR	0.00150376	0.43062187255338236
OCULAR ALBINISM WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00150376	0.43062187255338236
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.00150376	0.43062187255338236
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.00150376	0.43062187255338236
CONE-ROD DYSTROPHY AND HEARING LOSS 2; CRDHL2	0.00150376	0.43062187255338236
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.00150376	0.43062187255338236
DEAFNESS, AUTOSOMAL DOMINANT 59	0.00150376	0.43062187255338236
DEAFNESS, AUTOSOMAL RECESSIVE 113	0.00150376	0.43062187255338236
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.00150376	0.43062187255338236
DEAFNESS, AUTOSOMAL RECESSIVE 100; DFNB100	0.00150376	0.43062187255338236
DEAFNESS, AUTOSOMAL RECESSIVE 114; DFNB114	0.00150376	0.43062187255338236
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.00150376	0.43062187255338236
DEAFNESS, AUTOSOMAL RECESSIVE 115; DFNB115	0.00150376	0.43062187255338236
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.00150376	0.43062187255338236
DEAFNESS, AUTOSOMAL RECESSIVE 99	0.00150376	0.43062187255338236
NOONAN SYNDROME 11; NS11	0.00150376	0.43062187255338236
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.00150376	0.43062187255338236
DEAFNESS, AUTOSOMAL DOMINANT 27	0.00150376	0.43062187255338236
HYPOGONADOTROPIC HYPOGONADISM 5 WITH OR WITHOUT ANOSMIA	0.00150376	0.43062187255338236
DEAFNESS, AUTOSOMAL RECESSIVE 68	0.00150376	0.43062187255338236
FEINGOLD SYNDROME	0.00150376	0.43062187255338236
DYSTONIA, JUVENILE-ONSET	0.00150376	0.43062187255338236
DISTAL LIMB DEFICIENCIES-MICROGNATHIA SYNDROME	0.00150376	0.43062187255338236
CODAS SYNDROME	0.00150376	0.43062187255338236
COFS SYNDROME	0.00150376	0.43062187255338236
COGAN SYNDROME	0.00150376	0.43062187255338236
UVEAL COLOBOMA-CLEFT LIP AND PALATE-INTELLECTUAL DISABILITY	0.00150376	0.43062187255338236
CORNEAL DYSTROPHY-PERCEPTIVE DEAFNESS SYNDROME	0.00150376	0.43062187255338236
VICI SYNDROME	0.00150376	0.43062187255338236
DEAFNESS, AUTOSOMAL DOMINANT 43	0.00150376	0.43062187255338236
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 49	0.00150376	0.43062187255338236
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.00150376	0.43062187255338236
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE I, WITH COUGH AND GASTROESOPHAGEAL REFLUX	0.00150376	0.43062187255338236
CHROMOSOME 1P36 DELETION SYNDROME	0.00150376	0.43062187255338236
CRANIOMETAPHYSEAL DYSPLASIA	0.00150376	0.43062187255338236
CRANIOFACIAL-DEAFNESS-HAND SYNDROME	0.00150376	0.43062187255338236
FAMILIAL ISOLATED DILATED CARDIOMYOPATHY	0.00150376	0.43062187255338236
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.00150376	0.43062187255338236
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.00150376	0.43062187255338236
RETINAL CILIOPATHY DUE TO MUTATION IN USHER GENE	0.00150376	0.43062187255338236
CINCA SYNDROME	0.00150376	0.43062187255338236
OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.00150376	0.43062187255338236
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 28	0.00150376	0.43062187255338236
DEAFNESS, AUTOSOMAL RECESSIVE 23	0.00150376	0.43062187255338236
DEAFNESS, AUTOSOMAL DOMINANT 53	0.00150376	0.43062187255338236
DEAFNESS, AUTOSOMAL RECESSIVE 51	0.00150376	0.43062187255338236
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.00150376	0.43062187255338236
SPASTIC PARAPLEGIA 29, AUTOSOMAL DOMINANT	0.00150376	0.43062187255338236
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.00150376	0.43062187255338236
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 42	0.00150376	0.43062187255338236
SPONDYLOMEGAEPIPHYSEAL DYSPLASIA WITH UPPER LIMB MESOMELIA, PUNCTATECALCIFICATIONS, AND DEAFNESS	0.00150376	0.43062187255338236
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 2; PEOA2	0.00150376	0.43062187255338236
DEAFNESS, AUTOSOMAL DOMINANT 47	0.00150376	0.43062187255338236
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.00150376	0.43062187255338236
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.00150376	0.43062187255338236
MADRAS MOTOR NEURON DISEASE	0.00150376	0.43062187255338236
AUDITORY NEUROPATHY, AUTOSOMAL DOMINANT, 1	0.00150376	0.43062187255338236
CATARACT-DEAFNESS-HYPOGONADISM SYNDROME	0.00150376	0.43062187255338236
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.00150376	0.43062187255338236
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.00150376	0.43062187255338236
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.00150376	0.43062187255338236
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.00150376	0.43062187255338236
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.00150376	0.43062187255338236
OPTIC ATROPHY 7 WITH OR WITHOUT AUDITORY NEUROPATHY; OPA7	0.00150376	0.43062187255338236
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.00150376	0.43062187255338236
DEAFNESS, AUTOSOMAL DOMINANT 69	0.00150376	0.43062187255338236
DEAFNESS, AUTOSOMAL RECESSIVE 97	0.00150376	0.43062187255338236
DEAFNESS, AUTOSOMAL DOMINANT 68	0.00150376	0.43062187255338236
DESANTO-SHINAWI SYNDROME	0.00150376	0.43062187255338236
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13	0.00150376	0.43062187255338236
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 2	0.00150376	0.43062187255338236
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.00150376	0.43062187255338236
PERRAULT SYNDROME 2; PRLTS2	0.00150376	0.43062187255338236
PEROXISOME BIOGENESIS DISORDER 9B; PBD9B	0.00150376	0.43062187255338236
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.00150376	0.43062187255338236
PEROXISOME BIOGENESIS DISORDER 6B	0.00150376	0.43062187255338236
PEROXISOME BIOGENESIS DISORDER 5B	0.00150376	0.43062187255338236
SPLIT-FOOT MALFORMATION WITH MESOAXIAL POLYDACTYLY; SFMMP	0.00150376	0.43062187255338236
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.00150376	0.43062187255338236
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.00150376	0.43062187255338236
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.00150376	0.43062187255338236
OPTIC ATROPHY 8	0.00150376	0.43062187255338236
CRANIOSYNOSTOSIS 6; CRS6	0.00150376	0.43062187255338236
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.00150376	0.43062187255338236
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.00150376	0.43062187255338236
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2	0.00150376	0.43062187255338236
DEAFNESS, AUTOSOMAL RECESSIVE 103; DFNB103	0.00150376	0.43062187255338236
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.00150376	0.43062187255338236
IMMUNODEFICIENCY 23; IMD23	0.00150376	0.43062187255338236
ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS; ACPHD	0.00150376	0.43062187255338236
JOUBERT SYNDROME 21	0.00150376	0.43062187255338236
VAN MALDERGEM SYNDROME 2; VMLDS2	0.00150376	0.43062187255338236
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.00150376	0.43062187255338236
STEEL SYNDROME; STLS	0.00150376	0.43062187255338236
INFANTILE LIVER FAILURE SYNDROME 1	0.00150376	0.43062187255338236
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.00150376	0.43062187255338236
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.00150376	0.43062187255338236
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.00150376	0.43062187255338236
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.00150376	0.43062187255338236
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 50; MRT50	0.00150376	0.43062187255338236
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.00150376	0.43062187255338236
DEAFNESS, AUTOSOMAL DOMINANT 66	0.00150376	0.43062187255338236
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.00150376	0.43062187255338236
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.00150376	0.43062187255338236
DEAFNESS, AUTOSOMAL RECESSIVE 110; DFNB110	0.00150376	0.43062187255338236
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G; CMTDIG	0.00150376	0.43062187255338236
RETINITIS PIGMENTOSA 59; RP59	0.00150376	0.43062187255338236
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.00150376	0.43062187255338236
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.00150376	0.43062187255338236
DEAFNESS, AUTOSOMAL RECESSIVE 57; DFNB57	0.00150376	0.43062187255338236
DEAFNESS, AUTOSOMAL RECESSIVE 79; DFNB79	0.00150376	0.43062187255338236
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2N	0.00150376	0.43062187255338236
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5; PEOB5	0.00150376	0.43062187255338236
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00150376	0.43062187255338236
WAARDENBURG SYNDROME, TYPE 4B; WS4B	0.00150376	0.43062187255338236
NOONAN SYNDROME 6; NS6	0.00150376	0.43062187255338236
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.00150376	0.43062187255338236
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.00150376	0.43062187255338236
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00150376	0.43062187255338236
DEAFNESS, AUTOSOMAL DOMINANT 50	0.00150376	0.43062187255338236
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.00150376	0.43062187255338236
DEAFNESS, AUTOSOMAL RECESSIVE 29	0.00150376	0.43062187255338236
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.00150376	0.43062187255338236
PONTINE TEGMENTAL CAP DYSPLASIA	0.00150376	0.43062187255338236
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.00150376	0.43062187255338236
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	0.00150376	0.43062187255338236
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.00150376	0.43062187255338236
THAUVIN-ROBINET-FAIVRE SYNDROME	0.00150376	0.43062187255338236
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.00150376	0.43062187255338236
CONE-ROD DYSTROPHY AND HEARING LOSS; CRDHL	0.00150376	0.43062187255338236
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.00150376	0.43062187255338236
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.00150376	0.43062187255338236
STICKLER SYNDROME, TYPE V; STL5	0.00150376	0.43062187255338236
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.00150376	0.43062187255338236
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.00150376	0.43062187255338236
%614211 DEAFNESS, AUTOSOMAL DOMINANT 33; DFNA33	0.00150376	0.43062187255338236
DEAFNESS, AUTOSOMAL DOMINANT 71; DFNA71	0.00150376	0.43062187255338236
DEAFNESS, AUTOSOMAL DOMINANT 72; DFNA72	0.00150376	0.43062187255338236
DEAFNESS, AUTOSOMAL DOMINANT 64; DFNA64	0.00150376	0.43062187255338236
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.00150376	0.43062187255338236
NEUROPATHY, HEREDITARY SENSORY, TYPE IE; HSN1E	0.00150376	0.43062187255338236
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.00150376	0.43062187255338236
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.00150376	0.43062187255338236
DEAF BLIND HYPOPIGMENTATION SYNDROME, YEMENITE TYPE	0.00150376	0.43062187255338236
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.00150376	0.43062187255338236
COG5-CDG	0.00150376	0.43062187255338236
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.00150376	0.43062187255338236
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 6; CMTX6	0.00150376	0.43062187255338236
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.00150376	0.43062187255338236
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00150376	0.43062187255338236
KEIPERT SYNDROME	0.00150376	0.43062187255338236
NATHALIE SYNDROME	0.00150376	0.43062187255338236
NEPHROPATHY-DEAFNESS-HYPERPARATHYROIDISM SYNDROME	0.00150376	0.43062187255338236
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.00150376	0.43062187255338236
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.00150376	0.43062187255338236
MENTAL RETARDATION, X-LINKED 46	0.00150376	0.43062187255338236
FACIOSCAPULOHUMERAL DYSTROPHY	0.00150376	0.43062187255338236
NEUTROPENIA-MONOCYTOPENIA-DEAFNESS SYNDROME	0.00150376	0.43062187255338236
KNUCKLE PADS-LEUKONYCHIA-SENSORINEURAL DEAFNESS-PALMOPLANTAR HYPERKERATOSIS SYNDROME	0.00150376	0.43062187255338236
OCULOFACIOCARDIODENTAL SYNDROME	0.00150376	0.43062187255338236
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.00150376	0.43062187255338236
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.00150376	0.43062187255338236
IMMUNODEFICIENCY 47	0.00150376	0.43062187255338236
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.00150376	0.43062187255338236
KEIPERT SYNDROME; KPTS	0.00150376	0.43062187255338236
COFFIN-LOWRY SYNDROME; CLS	0.00150376	0.43062187255338236
ISOLATED SPLIT HAND-SPLIT FOOT MALFORMATION	0.00150376	0.43062187255338236
FRONTOMETAPHYSEAL DYSPLASIA	0.00150376	0.43062187255338236
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.00150376	0.43062187255338236
DEAFNESS, X-LINKED 1	0.00150376	0.43062187255338236
AUTOSOMAL RECESSIVE STICKLER SYNDROME	0.00150376	0.43062187255338236
1Q21.1 MICRODELETION SYNDROME	0.00150376	0.43062187255338236
MULTIPLE EPIPHYSEAL DYSPLASIA	0.00150376	0.43062187255338236
6Q25 MICRODELETION SYNDROME	0.00150376	0.43062187255338236
ALPORT SYNDROME, X-LINKED; ATS	0.00150376	0.43062187255338236
19P13.12 MICRODELETION SYNDROME	0.00150376	0.43062187255338236
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.00150376	0.43062187255338236
FABRY DISEASE	0.00150376	0.43062187255338236
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.00150376	0.43062187255338236
MOYNAHAN SYNDROME	0.00150376	0.43062187255338236
MYOPATHY AND DIABETES MELLITUS	0.00150376	0.43062187255338236
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.00150376	0.43062187255338236
OPITZ G/BBB SYNDROME	0.00150376	0.43062187255338236
DEAFNESS, X-LINKED 4	0.00150376	0.43062187255338236
%607017 DEAFNESS, AUTOSOMAL DOMINANT 21; DFNA21	0.00150376	0.43062187255338236
DE SANCTIS-CACCHIONE SYNDROME	0.00150376	0.43062187255338236
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.00150376	0.43062187255338236
ACROOTOOCULAR SYNDROME	0.00150376	0.43062187255338236
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO FKBP22 DEFICIENCY	0.00150376	0.43062187255338236
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	0.00150376	0.43062187255338236
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.00150376	0.43062187255338236
SHORT SYNDROME	0.00150376	0.43062187255338236
ROTHMUND-THOMSON SYNDROME	0.00150376	0.43062187255338236
RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY-DEAFNESS-HYPOGONADISM SYNDROME	0.00150376	0.43062187255338236
RETINITIS PIGMENTOSA INVERSA WITH DEAFNESS	0.00150376	0.43062187255338236
RENAL TUBULAR ACIDOSIS, DISTAL, WITH PROGRESSIVE NERVE DEAFNESS	0.00150376	0.43062187255338236
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA-DEAFNESS-NARCOLEPSY SYNDROME	0.00150376	0.43062187255338236
PEROXISOME BIOGENESIS DISORDER 3B	0.00150376	0.43062187255338236
REFSUM DISEASE	0.00150376	0.43062187255338236
SCLEROSTEOSIS	0.00150376	0.43062187255338236
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.00150376	0.43062187255338236
PRUNE BELLY SYNDROME WITH PULMONIC STENOSIS, MENTAL RETARDATION, ANDDEAFNESS	0.00150376	0.43062187255338236
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.00150376	0.43062187255338236
SPONDYLOPERIPHERAL DYSPLASIA	0.00150376	0.43062187255338236
FETAL CYTOMEGALOVIRUS SYNDROME	0.00150376	0.43062187255338236
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.00150376	0.43062187255338236
CHANARIN-DORFMAN SYNDROME	0.00150376	0.43062187255338236
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.00150376	0.43062187255338236
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.00150376	0.43062187255338236
LATERAL MENINGOCELE SYNDROME	0.00150376	0.43062187255338236
ENDOSTEAL HYPEROSTOSIS, WORTH TYPE	0.00150376	0.43062187255338236
WAARDENBURG-SHAH SYNDROME	0.00150376	0.43062187255338236
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.00150376	0.43062187255338236
USHER SYNDROME, TYPE IIIA	0.00150376	0.43062187255338236
SPASTIC PARAPARESIS-DEAFNESS SYNDROME	0.00150376	0.43062187255338236
CONGENITAL RUBELLA SYNDROME	0.00150376	0.43062187255338236
SPASTIC PARAPLEGIA-NEPHRITIS-DEAFNESS SYNDROME	0.00150376	0.43062187255338236
STIFF SKIN SYNDROME	0.00150376	0.43062187255338236
RENAL CALICEAL DIVERTICULI-DEAFNESS SYNDROME	0.00150376	0.43062187255338236
SHORT STATURE-DEAFNESS-NEUTROPHIL DYSFUNCTION-DYSMORPHISM SYNDROME	0.00150376	0.43062187255338236
PIEBALD TRAIT-NEUROLOGIC DEFECTS SYNDROME	0.00150376	0.43062187255338236
AUTOSOMAL RECESSIVE HYPOPHOSPHATEMIC RICKETS	0.00150376	0.43062187255338236
THYROCEREBRORETINAL SYNDROME	0.00150376	0.43062187255338236
LAURENCE-MOON SYNDROME	0.00150376	0.43062187255338236
COWCHOCK SYNDROME; COWCK	0.00150376	0.43062187255338236
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5	0.00150376	0.43062187255338236
KALLMANN SYNDROME-HEART DISEASE SYNDROME	0.00150376	0.43062187255338236
AMISH INFANTILE EPILEPSY SYNDROME	0.00150376	0.43062187255338236
DEAFNESS, AUTOSOMAL RECESSIVE 14	0.00150376	0.43062187255338236
NEUROENDOCRINE CARCINOMA OF SALIVARY GLANDS, SENSORINEURAL HEARING LOSS, AND ENAMEL HYPOPLASIA	0.00150376	0.43062187255338236
CDAGS SYNDROME	0.00150376	0.43062187255338236
DEAFNESS, AUTOSOMAL RECESSIVE 13	0.00150376	0.43062187255338236
MYH9-RELATED DISEASE	0.00150376	0.43062187255338236
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.00150376	0.43062187255338236
FRONTOMETAPHYSEAL DYSPLASIA	0.00150376	0.43062187255338236
DEAFNESS, AUTOSOMAL RECESSIVE 17; DFNB17	0.00150376	0.43062187255338236
MUENKE SYNDROME	0.00150376	0.43062187255338236
SEVERE COMBINED IMMUNODEFICIENCY	0.00150376	0.43062187255338236
ECTODERMAL DYSPLASIA-SENSORINEURAL DEAFNESS SYNDROME	0.00150376	0.43062187255338236
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00150376	0.43062187255338236
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 18	0.00150376	0.43062187255338236
EEC SYNDROME	0.00150376	0.43062187255338236
COCKAYNE SYNDROME	0.00150376	0.43062187255338236
FETAL IODINE SYNDROME	0.00150376	0.43062187255338236
DEAFNESS, AUTOSOMAL RECESSIVE 16; DFNB16	0.00150376	0.43062187255338236
DEAFNESS, AUTOSOMAL RECESSIVE 20; DFNB20	0.00150376	0.43062187255338236
CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT; ADCADN	0.00150376	0.43062187255338236
%605818 DEAFNESS, AUTOSOMAL RECESSIVE 27; DFNB27	0.00150376	0.43062187255338236
USHER SYNDROME, TYPE IG	0.00150376	0.43062187255338236
DEAFNESS, AUTOSOMAL DOMINANT 30	0.00150376	0.43062187255338236
1P36 DELETION SYNDROME	0.00150376	0.43062187255338236
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.00150376	0.43062187255338236
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.00150376	0.43062187255338236
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.00150376	0.43062187255338236
SPONDYLOOCULAR SYNDROME; SOS	0.00150376	0.43062187255338236
DEAFNESS, AUTOSOMAL DOMINANT 25	0.00150376	0.43062187255338236
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.00150376	0.43062187255338236
AUTOSOMAL DOMINANT OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.00150376	0.43062187255338236
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.00150376	0.43062187255338236
DEAFNESS, AUTOSOMAL RECESSIVE 26	0.00150376	0.43062187255338236
CARDIOMYOPATHY, DILATED, 1J; CMD1J	0.00150376	0.43062187255338236
DEAFNESS, AUTOSOMAL DOMINANT 23; DFNA23	0.00150376	0.43062187255338236
STICKLER SYNDROME, TYPE II	0.00150376	0.43062187255338236
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B2; CMT4B2	0.00150376	0.43062187255338236
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00150376	0.43062187255338236
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 13	0.00150376	0.43062187255338236
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.00150376	0.43062187255338236
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 2	0.00150376	0.43062187255338236
DONNAI-BARROW SYNDROME	0.00150376	0.43062187255338236
HIRSCHSPRUNG DISEASE-DEAFNESS-POLYDACTYLY SYNDROME	0.00150376	0.43062187255338236
HYPERTRYPTOPHANEMIA; HYPTRP	0.00150376	0.43062187255338236
CHROMOSOME 2Q37 DELETION SYNDROME	0.00150376	0.43062187255338236
PALMOPLANTAR KERATODERMA-DEAFNESS SYNDROME	0.00150376	0.43062187255338236
CODAS SYNDROME	0.00150376	0.43062187255338236
MATERNALLY-INHERITED DIABETES AND DEAFNESS	0.00150376	0.43062187255338236
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.00150376	0.43062187255338236
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 5	0.00150376	0.43062187255338236
8Q12 MICRODUPLICATION SYNDROME	0.00150376	0.43062187255338236
DEAFNESS, Y-LINKED 2; DFNY2	0.00150376	0.43062187255338236
DEAFNESS, Y-LINKED 1	0.00150376	0.43062187255338236
USHER SYNDROME TYPE 1	0.00150376	0.43062187255338236
USHER SYNDROME TYPE 2	0.00150376	0.43062187255338236
USHER SYNDROME TYPE 3	0.00150376	0.43062187255338236
NON-ACQUIRED COMBINED PITUITARY HORMONE DEFICIENCY-SENSORINEURAL HEARING LOSS-SPINE ABNORMALITIES SYNDROME	0.00150376	0.43062187255338236
ENLARGED VESTIBULAR AQUEDUCT	0.00150376	0.43062187255338236
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 7	0.00150376	0.43062187255338236
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.00150376	0.43062187255338236
GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION	0.00150376	0.43062187255338236
CHROMOSOME 18Q DELETION SYNDROME	0.00150376	0.43062187255338236
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 3	0.00150376	0.43062187255338236
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 12	0.00150376	0.43062187255338236
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.00150376	0.43062187255338236
CORNELIA DE LANGE SYNDROME	0.00150376	0.43062187255338236
VAN MALDERGEM SYNDROME 1; VMLDS1	0.00150376	0.43062187255338236
EAST SYNDROME	0.00150376	0.43062187255338236
CRANDALL SYNDROME	0.00150376	0.43062187255338236
BRAIN-LUNG-THYROID SYNDROME	0.00150376	0.43062187255338236
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	0.00150376	0.43062187255338236
GINGIVAL FIBROMATOSIS-PROGRESSIVE DEAFNESS SYNDROME	0.00150376	0.43062187255338236
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 10	0.00150376	0.43062187255338236
GEMIGNANI SYNDROME	0.00150376	0.43062187255338236
AYME-GRIPP SYNDROME; AYGRP	0.00150376	0.43062187255338236
DEAFNESS, CHILDHOOD-ONSET NEUROSENSORY, AUTOSOMAL RECESSIVE 8	0.00150376	0.43062187255338236
DEAFNESS, AUTOSOMAL RECESSIVE 9	0.00150376	0.43062187255338236
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2A2	0.00150376	0.43062187255338236
